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ABSTRACT
An experiment was conducted to determine effects of anti-Salmonella egg
yolk antibodies (ASEYA) on shedding and antibiotic resistance of Salmonella
enterica Typhimurium and E. coli, growth performance and immunological
parameters. Weaned pigs in two replicate trials (n = 132) were randomly assigned to
six dietary treatments, including a control diet without additives, apramycin followed
by carbadox, oxytetracycline (OXY), egg yolk powder containing ASEYA, egg yolk
powder lacking ASEYA, or spray dried plasma protein (SDPP). Treatments were
given to pigs on day 3 of the trial and all pigs were intranasally and orally challenged
with Salmonella Typhimurium containing a nalidixic acid resistance marker on day 7.
Fecal samples were collected on day 0, 7, 8, 12, 14, 21, 58, 88, and 118 for detection
of Salmonella and E. coli to determine shedding and antibiotic resistance. Blood
samples were collected and rectal temperatures (RT) were measured on day 0, 7, 8,
12, 14, 21, and 28. Blood was analyzed for white blood cell (WBC) counts and
serum was analyzed for Salmonella antibody and interleukin-1β (IL-1β).

The

percentage of pigs shedding Salmonella was lower (P<0.05) for antibiotic treatments
compared to other diets; however, resistance was greater (P<0.05) in E. coli from pigs
fed antibiotics. Weight gains did not differ between treatments. Pigs fed OXY had
lower RT compared to pigs fed SDPP and ASEYA (P<0.05); however, pigs in all
groups had higher RT 24 h after challenge (P<0.05) and had decreasing RT by day
12. Concentrations of anti-Salmonella antibodies and WBC counts did not differ
between treatment groups.

Salmonella antibody concentrations increased in all
iii

groups beginning on day 14 and continued to increase through day 28 (P<0.05). IL1β was generally below detection limits. These studies indicate that in-feed ASEYA
may not be effective in controlling shedding of Salmonella or improving the
performance or health status of pigs challenged with Salmonella likely because
ASEYA cannot reach invasive Salmonella that move through routes outside of the GI
tract and/or because ASEYA lose activity as a result of animal digestive processes.
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PART I. INTRODUCTION

1

Salmonella infections were identified as the most common pathogenic diseases of
humans in 2004 by the Foodborne Diseases Active Surveillance Network (FoodNet)
(Centers for Disease Control and Prevention, 2005). In the United States, Salmonella is
estimated to cause 1.4 million human illnesses and approximately of 590 deaths annually
(Mead et al., 1999). In 2005, the Economic Research Service estimated that the annual
economic cost of human salmonellosis, the illness caused by the Salmonella bacterium, is
$2.4 billion which includes medical costs due to acute illness, the value of time lost from
work due to chronic illness, and the cost of premature death (Economic Research Service,
2006).

Infection caused by Salmonella enterica subspecies enterica serovar

Typhimurium can be detected in both humans and animals. In human cases, most
Salmonella infections occur via foodborne transmission and others through animal
contact or environmental spread (Rice et al., 2003; Centers for Disease Control and
Prevention, 2001; Besser et al., 2000). In animal cases, especially in swine, Salmonella
pathogen causes serious enteric and systemic infections, frequently in young pigs
(Ekperigin and Nagaraja, 1998). However, farm animals, which carry bacteria in their
intestine, are most likely the source for human salmonellosis (Oosterom, 1991).
Frequently, Salmonella bacteria in pigs are spread among animals prior to slaughter,
particularly in the period of holding and transport (Hurd et al., 2002). In this case,
Salmonella contaminated feces is the major transmission source of the pathogen (Beloeil
et al., 2004). Salmonella contamination of holding pens, water (Rostagno et al., 2003),
vehicle floors, and bedding material during transportation (Rajkowski et al., 1998) as
well as animal stress during transportation (Berends et al., 1996) can be additional factors
for Salmonella spread among pigs. The contaminated environment may also stimulate
2

Salmonella infection in market pigs and this possibly influences pork safety (Hurd et al.,
2001).
Antimicrobial agents are used in animals for treatment of bacterial infection,
prevention of disease, control of sick animals in large groups, and for growth promotion
(Schwarz et al., 2001). Several studies have demonstrated that the use of antibiotics in
food animals can lead to the development of drug resistance and associated risks to
humans since resistant bacteria are transferred by the food chain (Van den Bogaard and
Stobberingh, 2000) and are indirectly disseminated from animals to man (Mazel and
Davies, 1999). Other ways in which humans obtain resistant bacteria are direct personal
contact and environmental exposure.

Some researchers have studied the risks of

antibiotic use in food animals to human health (Phillips et al., 2004). There has been
increasing concern by regulating agencies over similar or identical drugs used in humans
and animals because of the potential for bacteria to become antibiotic resistant and affect
human medicine alternatives, possibly resulting in increased sickness and death (Cox and
Popken, 2006).
Currently, antibiotic alternatives are being studied for their roles in improving
food safety. Several alternatives to antibiotics in animal feed for improved growth and/or
to minimize intestinal infectious disease have been investigated, including spray dried
plasma (Bosi et al., 2004), zinc oxide, fumaric acid (Owusu-Asiedu et al., 2003),
probiotics (Zeyner and Boldt, 2006), and prebiotics (Tzortzis et al., 2005). A recent
novel approach, chicken egg yolk antibodies, has been proposed for passive treatment of
bacterial infections in young animals (Wiedemann et al., 1991). Neonatal and earlyweaned piglets that experimentally received egg yolk antibodies were protected against
3

enterotoxigenic E. coli infection and had increased weight gains and a high survival rate
(Marquardt et al., 1999).

Chicken egg yolk antibodies represent an alternative to

antibiotic therapies (Wiedemann et al., 1991).

Verifying this strategy of egg yolk

antibody supplementation, as applied toward control of Salmonella infection in pigs, was
the emphasis of this investigation.

Research Objectives
This study was designed to determine the effects of in-feed egg yolk powder
containing anti-Salmonella egg yolk antibodies (ASEYA), egg yolk powder lacking
ASEYA, spray dried porcine plasma (SDPP), and antibiotics on colonization and
shedding of Salmonella enterica Serovar Typhimurium and non-pathogenic E. coli,
antibiotic resistance in Salmonella and naturally occurring E. coli, and growth
performance and immunological parameters of pigs.
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PART II. LITERATURE REVIEW

9

Overview of Salmonella
Salmonella, recognized as a “zoonotic” pathogen, commonly colonize humans
and most animals (Libby et al., 2004). The genus Salmonella was named to recognize D.
E. Salmon, the American bacteriologist, who in 1880s, identified the bacteria, which
caused hog cholera (D’Aoust, 1989).

Eventually, Salmonella enterica serotype

Choleraesuis was named for this infectious bacteria. Salmonella bacteria, members of the
Enterobacteriaceae family, are facultatively anaerobic, non-spore-forming, non-lactose
fermenting Gram-negative rods (Ekperigin and Nagaraja, 1998). Their optimal growth
temperature is at 37 ºC (Libby et al., 2004). These bacteria have been classified on the
basis of the Kauffmann-White scheme, which mostly depends on H (flagella), O
(somatic) antigens, and Vi (a capsular polysaccharide) antigens (Libby et al., 2004). To
date, almost 2,545 serotypes of Salmonella have been identified (Popoff et al., 2004) and
Salmonella species are recognized as very important foodborne and waterborne
organisms, which cause different degrees of disease severity (Bell and Kyriakides, 2002).
Salmonella have been classified into two species, Salmonella enterica and Salmonella
bongori.

There are six subspecies of Salmonella enterica, described as enterica,

salamae, arizonae, diarizonae, houtenae, and indica. Salmonella enterica subspecies
enterica is likely to inhabit birds and mammals, and represents approximately 60% of
Salmonella serotypes (Libby et al., 2004). Within a serotype, plasmid content, biotype
and phage type are used to identify the variation of phenotypes and to create sub-types
(Ekperigin and Nagaraja, 1998). Phage typing is based on “sensitivity of bacterial cells
to the lytic activity of selected bacteriophages”. This procedure has been recently applied
10

to other serotypes of Salmonella, including Salmonella Typhimurium with the phage type
referring to “provisional phage type (PT) and definitive phage type (DT)” (Bell and
Kyriakides, 2002).

Among Salmonella serotypes isolated from human sources,

Salmonella enterica serovar Typhimurium is frequently reported and normally causes
acute gastroenteritis (Lax et al., 1995). Salmonella Typhimurium can infect a variety of
hosts, whereas several other serotypes, for example, Salmonella Choleraesuis, Salmonella
Typhi, Salmonella Dublin and Salmonella Pullorum, cause diseases in specific hosts, i.e.,
pig, human, cattle and poultry, respectively. This distinction has been called “serotypehost specificity”, “host adaptation” or “host restriction” (Watson et al., 2000).
Salmonella primarily occupy the intestinal tract of humans and animals; therefore, they
are commonly disseminated into the environment, including soil and water, where they
possibly survive for long periods (Bell and Kyriakides, 2002).

Salmonella in Swine
A study of foodborne disease observed that pork was responsible for Salmonella
outbreaks (Delpech et al., 1998). At the slaughterhouse, pigs are recognized as a source
of contamination and transmission which possibly occurs by close contact among animals
or exposure to the contaminated environment (Williams and Newwell, 1970; Botteldoorn
et al., 2003).

Additionally, contaminated pigs may come from a group previously

impacted by Salmonella outbreaks at the pre-harvest operation (Oliveira et al., 2005). In
pigs, Salmonella infections are linked to “significant animal suffering and economic
impact” and they may be a source of transmission to humans (Berends et al., 1997).
Salmonella serotypes generally involved in systemic infections in swine salmonellosis are
Salmonella Choleraesuis and Salmonella Typhimurium, but the enteric infection form is
11

more related to Salmonella Typhimurium (Ekperigin and Nagaraja, 1998). In addition,
some serotypes may reside for long periods in hosts as contaminated sources and cause
infection when stress is induced, including during shipping to the slaughterhouse (Libby
et al., 2004). One study shows that Salmonella Typhimurium was the most predominant
serotype isolated from pig samples (43%) and in environmental samples (33%) from
slaughterhouses in the Netherlands (Swanenberg et al., 2001).

Salmonella Pathogenesis
Salmonellosis
With Salmonella infection in humans, people develop the symptoms of diarrhea,
fever, and abdominal cramps for 12 to 72 h after infection, which lasts 4 to 7 days. Most
people recover without treatment. However, in the cases of severe diarrhea, the person
needs to be hospitalized. In these patients, the Salmonella infection may disperse from
the intestines to the blood circulation, and then enter other body sites and, finally, death
may occur unless the person is treated properly with antibiotics. The elderly, infants, and
those with impaired immune systems are more likely to have a severe illness (Centers for
Disease Control and Prevention, 2005).
In several countries, the incidence of salmonellosis is high in swine, particularly
those in the growing phase (Reed et al., 1986). In animals, sub-clinical infection is usual
and many animals may become carriers. Cattle and calves are likely to suffer severe
diarrhea and high fever during the Salmonella acute infection and high mortality is also
observed in calves (Bertoldo, 2006). Salmonellosis in swine exhibits the symptoms in

12

two forms, a systemic form and an enteric form. This is dependent on several factors,
including the Salmonella strain, the dose, and the disease resistance of the infected
animal (Hirsh, 2004). The incubation period is normally 1-2 days. In the enteric form,
the clinical signs of “a watery, yellow, fetid diarrhea” with or without the appearance of
blood may last 3 to 7 days and then may occur again one or more times. Other symptoms
such as moderate fever and dehydration may be observed. The incidence of mortality is
low and occurs only after several days of diarrhea. In the systemic form, additional
symptoms can be detected, including “anorexia, fever of 40.5-41.6 °C, cough and
dyspnea”. Pigs shed Salmonella for several months after infection and can become a
source of contamination. Swine salmonellosis is commonly found in weaned pigs raised
in intensive livestock systems (Ekperigin and Nagaraja, 1998).

Salmonella Infection
The consequences of Salmonella infections, including enteric and systemic
infections, carrier state, and high mortalities are serious problems, which widely occur in
humans and animals (Libby et al., 2004). The severity of infection caused by Salmonella
Typhimurium depends on several factors including condition of the host species (Morgan
et al., 2004).

A minimum dose of 103 CFU/ml for acute infection involving both

intestinal and other tissues, particularly in swine, has been reported by Loynachan and
Harris (2005). Animal feed contaminated with Salmonella is considered as a significant
source of Salmonella infection (Berends et al., 1996). After Salmonella are ingested, the
invasive Salmonella are either killed by protective systems, excreted from the body, or
survive in the host (Ekperigin and Nagaraja, 1998). If Salmonella survive and initiate the
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infectious process, salmonellosis occurs (Ekperigin and Nagaraja, 1998). Tsolis and
coworkers (1999) indicated that Salmonella attach to intestinal epithelial cells before
invading and causing systemic infection and diarrhea. However, Salmonella pathogens
are able to release secretory products, including effector proteins to activate infection
(Zhang et al., 2003). Salmonella predominantly attach to the portion of the ileum mucosa
close to the ileocecal valve. They then move into the body (Salyers and Whitt, 2002)
through the sites of penetration called “Peyer’s patches, which contain specialized
membranous epithelium cells called microfold cells or M cells, in the follicle-associated
epithelium that overlay collections of lymphoid cells” (Libby et al., 2004; Jepson and
Clark, 2001).

In some species, including Rhesus monkeys and the guinea pig,

Salmonella are likely to interact with villi of enterocytes in contrast to M cells (Salyers
and Whitt, 2002). In the early stages of infection, Meyerholz and coworkers (2002)
demonstrated that bacterial attachment to M cells was experimentally observed within 5
minutes after inoculation, and bacterial penetration of the apical membrane was detected
in M cells, goblet cells, and enterocytes by 10 minutes.

A number of adhesion

mechanisms including type 1 fimbriae (fim genes), plasmid encoded fimbriae (pef genes),
long polar-fimbriae (lpf genes) and thin aggregative fimbriae (agf genes) are used by
Salmonella to facilitate infection (Salyers and Whitt, 2002; Libby et al., 2004).
Furthermore, Salmonella also have several virulence factors, which play important roles
during invasion and inflammation. These include: 1) Type III secretion genes clustered
in regions called “Salmonella Pathogenicity Islands (SPIs)” (Groisman and Ochman,
1997), described as SPI-1 to SPI-5, which cause membrane ruffling (invasion),
penetration of intestinal epithelium (Brown et al., 2005), inflammation and fluid
14

accumulation, 2) Salmonella virulence plasmids that encode genes required for the ability
to cause systemic disease (Gulig and Doyle, 1993), 3) lipopolysaccharide (LPS), a part of
the outer membrane and an infection factor, which triggers the immune system of host
and can cause increased severity (Libby et al., 2004), and 4) flagella which stimulate
intestinal invasiveness, polymorphonuclear leukocytes recruitment, and fluid secretion,
particularly in infected calves (Schmitt et al., 2001).

Salmonella can move into

membrane-bound endocyte vacuoles via the cell membrane ruffling mechanism which is
caused by the interaction with M cell (Francis et al., 1992; Finlay et al., 1991). In
addition, internalized invasive Salmonella Typhimurium impair the M cells.

The

alteration of M cells results in a change of gap in the follicle-associated epithelium,
which promotes organisms to move through the apical and basolateral surfaces of
enterocytes near damaged M cells (Jones et al., 1994). In vitro studies simulating the calf
model of enterocolitis have shown that during the complex series of host-pathogen
interactions causing diarrhea, type III secreted effector proteins, including SipA, SopA,
SopB, SopD, and SopE2, are released from Salmonella Typhimurium into host cells
(Zhang et al., 2002), and are required for the movement of neutrophils, presumably by
inducing the production of chemoattractant chemokines in bovine ileal tissue.

The

phenomenon of increased vascular permeability resulting in mucosal edema is a response
to inflammation. The damaged enterocytes cause leakage of fluid from blood and a large
infiltration of neutrophils into the intestinal lumen, which can be observed by the
excretion of fluids (Zhang et al., 2003).
At the initiation of infection, Salmonella Typhimurium activate signal
transduction pathways, and then are able to enter into the intestinal epithelium, penetrate
15

and reside within host cells (Khullar et al., 2003). These pathways are stimulated by
Salmonella type III secretion proteins, which are released in the host cell and induce
various responses (Finlay and Cossart, 1997) and cause cytoskeletal changes (Santos et
al., 2003). Mitogen-activated protein kinases and phospholipase C associate with these
pathways triggered during infectious process (Pace et al., 1993). Some research has
demonstrated that Salmonella are able to access Henle-407 cells by mobilizing free
calcium inside the cells, producing leukotriene D4 and activating phospholipase A2 (Pace
et al., 1993). Further information about the signals used by Salmonella Typhimurium to
enter cultured cells comes from work that describes the activation of the epidermal
growth factor receptor in response to Salmonella Typhimurium in Henle-407 cells (Galan
et al., 1992). This is also associated with intermediates of phosphatidylinositol 3-kinase,
phospholipase D, and protein kinase C (Procyk et al., 1999). Khullar and coworkers
(2003) indicated that greater levels of calcium and inositol 1,4,5-triphosphate inside
intestinal cells have been detected in Salmonella Typhimurium grown under anaerobic
condition in comparison to those grown under aerobic condition. Lee and Falkow (1990)
observed that Salmonella Typhimurium had more virulence and penetration in the distal
ileum, the target site of infection with anaerobic condition (pO2 of 5-40 mmHg). In the
mechanism of signal activation, phosphatidylinositol 4,5-bisphosphate, membrane
phospholipids, is hydrolyzed by phospholipase C gamma which results in the production
of diacylglycerol and inositol 1,4,5-triphosphate. These components and calcium ions
potentially activate protein kinase C (Su et al., 2006), thereby possibly inducing some
mechanisms to alter the cell membrane, express genes, or act through metabolic reactions
(Kikkawa et al., 1986).
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Libby and coworkers (2004) stated that Salmonella passed through the thoracic
duct and lymphatic systems, then replicated in macrophages residing in inner organs, i.e.,
lymph nodes, liver, and spleen. A study of Salmonella Typhimurium systemic infection
in mice demonstrated that these pathogens were detected in visceral organs, including the
mesenteric lymph nodes, spleen, liver, Peyer's patches, gall bladder, and cecum during
several weeks of acute infectious disease (Monack et al., 2004). They remained in these
organs, particularly in macrophages of mesenteric lymph nodes after several months of
infection. This is indicated that they were able to disperse in the lymphatic circulation.
Furthermore, they mostly appear in the ileocolic lymph nodes and in the ileum. This
perhaps leads to Salmonella shedding in feces (Vieira-Pinto et al., 2005). In a related
study, over 90% of pigs infected with Salmonella Typhimurium had the organisms in
mesenteric lymph nodes, tonsils, cecum, and feces (Schneider, 2003).

To survive

systemically, Salmonella Typhimurium uses several SPI-1 encoded type III secretion
system effectors/translocases (Lawley et al., 2006).

Host Immunity
Salmonella infection is described as intestinal epithelium penetration and survival
of bacteria in systemic circulation (Bloom and Boedeker, 1996). In response to the
bacterial infection, both innate immunity and adaptive immunity are required to protect
the host. Innate immune systems associate with the intestinal epithelium, neutrophils,
macrophages, dendritic cells, and natural killer cells, and the adaptive immune
mechanisms involve with specific T lymphocytes and B lymphocytes (Mizuno, 2004).
The mechanism for innate immune response to the microorganism is as follow. Briefly,
the innate immune system recognizes conserved molecular pattern of microorganism,
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called “Pathogenic-Associated Molecular Patterns” with the association of germ-line
encoded receptors, referred to as “Pattern Recognition Receptors” (Medzhitov and
Janeway, 1997). However, the adaptive immune response is activated with the basis of
“clonal selection of lymphocytes” expressing receptors with specific recognition
(Medzhitov and Janeway, 1998).

During the early period of an infection, the roles of

phagocytic cells are to control bacterial multiplication and to produce chemical
messengers, i.e., cytokines and chemokines which induce and recruit additional cells
(Wick, 2004) in order to control the invasive bacteria (Medzhitov and Janeway, 1997).
In the initiation of innate immune response, Toll-like receptors (TLRs) are important for
the interaction between the microbes and phagocytic cells (Li and Cherayil, 2003),
including macrophages, neutrophils and dendritic cells (Wick, 2004).

For example,

TLR4 interacts with lipopolysaccharide and then activates cellular reactions (Tapping et
al., 2000). Additionally, bacterial flagellins, necessary for microbial movement, are able
to trigger the host immune system. Pro-inflammatory response and dendritic cells are
activated by contact between flagellin and TLR5 (Salazar-Gonzalez and McSorley,
2005). In intestinal infection, distribution of pathogen can efficiently be protected by
rapid neutrophil attraction; meanwhile delayed movement of neutrophils during systemic
infection cannot inhibit circulating bacteria (Cheminay et al., 2004). To effectively
control and eliminate bacteria, adaptive immunity is crucial (Mittrucker and Kaufmann,
2000) which includes cell-mediated immunity and antibody production (Bloom and
Boedeker, 1996). During Salmonella infection, specific T cells are activated in primary
and secondary response and B cells are also induced to produce antibody in response to
Salmonella antigens (Mittrucker and Kaufmann, 2000). For instance, antibodies and
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CD4+ T cells specifically target flagellins of Salmonella during infection (SalazarGonzalez and McSorley, 2005).

In body circulation, specific antibodies, such as

immunoglobulin G, produced against Salmonella-epitopes, are able to bind and promote
migration of bacteria to phagocytic cells (Hirsh, 2004). At the level of local immune
responses in intestine, the secretion of immunoglobulin A (IgA), a class of antibodies,
can recognize and bind bacteria, thereby inhibiting their colonization or invasion into the
intestinal mucosa (Neutra and Kraehenbuhl, 1993). Fever accounts for the common
aspect of innate immunity in response to infectious pathogens (Ellis et al., 2005). During
acute infectious response, fever is regulated in the brain and activated by pyrogens.
Endogenous pyrogens, including interleukin-1β (IL-1β), are produced by host immune
cells, i.e., macrophages when triggered with exogenous pyrogens, such as LPS from
Gram-negative bacteria (Fabricio et al., 2005).

IL-1β activates prostaglandin E2

synthesis, which induces fever reaction (Sanchez-Alavez et al., 2006). IL-1β circulates to
the anterior hypothalamus and activates preoptic neurons to secrete prostaglandin E,
which alter the brain thermoregulator to set the higher body temperature (Tortora and
Grabowski, 1993).

Salmonella Defensive Mechanisms in Hosts
To move into the small intestine, microorganisms have to survive exposure to the
acidic condition in the stomach or the gastric acidic barrier, which varies depending on
different feed types ingested (Libby et al., 2004).

Under exposure of a low pH

environment (pH 3), Salmonella have the ability to adapt with an acid resistant response;
therefore they can survive in this environment, which includes both inorganic and organic
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acids (Garcia-del Portillo et al., 1993; Libby et al., 2004). Salmonella exhibit acidresistant systems between the log phase and stationary phase of growth (Audia et al.,
2001; Lee et al., 1995). In the log phase, the system is controlled by the iron uptake
regulator (Fur) providing a moderate degree of acid tolerance and in the stationary phase
the alternate sigma factor (RpoS), including PhoP and OmpR defined as “acid-response
regulators” are necessary for the more effective resistance system (Lee et al., 1995; Libby
et al., 2004; Hirsh, 2004). Additionally, when the mechanisms and antimicrobial factors
of host defense, including “bile salts, intestinal mucus, lysozyme, lactoferrin, organic
acids and peristalsis in intestine and normal flora in large intestine” are damaged,
Salmonella are able to colonize and cause infection (Libby et al., 2004). For further
Salmonella defensive mechanisms, Salmonella have to resist host protective immune
systems (Lawley et al., 2006). After adherence, Salmonella move into M cells by moving
through intestinal barriers (Clark et al., 1994). After reaching the lamina propria of the
intestinal cell wall, Salmonella confront resident tissue macrophages in M cells.
Salmonella survive inside the phagocytic cells without being killed (Fields et al., 1986).
The ability of Salmonella to cause death of the phagocytes by apoptosis and replicate
within phagocytic cells is a potential way to initiate infection, to survive and to escape the
host immune killing systems (Monack et al., 1996; Lindgren et al., 1996). Additionally,
Salmonella need to resist both “the oxygen-independent and oxygen-dependent killing
processes of phagocytes” in order to survive within intestinal tract and become systemic
(Libby et al., 2004). Mostly, Salmonella resistance is associated with resistance to
oxygen-dependent killing systems (Vazquez-Torres and Fang, 2001). In these killing
mechanisms of phagocytes, i.e., neutrophils, eosinophils and mononuclear phagocytes,
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the productions of oxygen-dependent metabolites produced by phagocytic cells play
important roles in impairing microbial components (Demple and Halbrook, 1983).
Phagocytic cells are associated with the mechanism of “respiratory burst” which
produces superoxide anion (⋅O2-) via the reaction of nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase and most of this O2- reacts with H+, generating the
productions of oxygen and hydrogen peroxide (H2O2) (Babior, 1984). The process of
“respiratory burst” producing reactive oxygen and derivatives which include superoxide
anion: O2-, hydrogen peroxide: H2O2, and nitrogen species, i.e., peroxynitrite: ONOO-, is
the predominant mechanism to kill bacteria (Schlosser-Silverman et al., 2000; Mastroeni
et al., 2000; Vazquez-Torres et al., 2000a).

Likewise, Salmonella are killed by

phagocytes with toxic oxygen generated by NADPH oxidase process following
phagocytosis (Vazquez-Torres and Fang, 2001).

However, under aerobic condition,

Salmonella have developed various strategies to efficiently overwhelm oxidative killing,
which include producing enzymes, i.e., superoxide dismutases, hydroperoxidases,
oxidoreductases, repairing systems, suppressing respiratory burst activity and
complement binding, inhibiting NADPH oxidase and nitric oxide synthase movement
towards the Salmonella-containing vacuole (Vazquez-Torres and Fang, 2001; Donne et
al., 2005; Knodler and Steele-Mortimer, 2003; Vazquez-Torres et al., 2000b).
Mechanisms including limited nutrients, increased production of degradative enzymes,
production of antimicrobial peptides, reduced phagosomal pH, and induced defensins are
involved in oxygen-independent killing (Finlay and Falkow, 1997; Groisman et al.,
1992). To resist the killing systems, there are several Salmonella genes associated, such
as SPI-2, SPI-3, SPI-4 and SPI-5, that encode for proteins required to survive and grow
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inside macrophages, plasmid encoded Spv, necessary for the intracellular growth and
serum resistance, systemic encoded PhoQ/PhoP genes, important for resistance to
defensins, and SlyA encoded genes, needed for resistance to the products of oxygen
dependent killing mechanisms (Hirsh, 2004).

Control and Treatment of Disease
In several countries, controlling strategies at the farm level to diminish
Salmonella incidence in food animals have been emphasized since Salmonella can
become a source of human salmonellosis (Fedorka-Cray et al., 1999; Dahl et al., 1997;
Letellier et al., 2000). To efficiently control Salmonella on the farm, animals need
increased pathogen resistance (Letellier et al., 2001). For the farm practices, Berends and
coworkers (1996) state that pen hygiene is an important way to control Salmonella. Care
in the nursery is also a principle management method to treat Salmonella intestinal
infection (Hirsh, 2004). Salmonella bacteria are not commonly found in animal feed
(Morrow, 2000). For feeding practices, providing liquid feed and on-farm mixing of feed
are good strategies for Salmonella protection (Wegener and Baggesen, 1996).

In

addition, vaccine administration can decrease the severity of infections (Lumsden and
Wilkie, 1992). This can significantly lower colonization of tissues and organs and
Salmonella Typhimurium shedding (Roesler et al., 2004) or prevent clinical porcine
salmonellosis. Providing therapeutic compounds including antimicrobial drugs, fluids,
electrolytes, and non-steroidal anti-inflammatory drugs can also treat Salmonella
infection (Ekperigen and Nagaraja, 1998). Since Salmonella grow inside the host cells
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during infectious disease and survives in phagocytes, the selected drugs for treatment
should be intracellularly active in order to increase efficiency of therapy (Hirsh, 2004).

Antibiotic Uses in Agriculture
For animal production in the United States, 18 million pounds of antibiotics are
used annually (Roe and Pillai, 2003) and approximately 40% of those are used in animal
feed (Prescott, 1997). In Australia, a report shows that over 50% of imported drugs were
used in animal feed during 1992-1993 and 1996-1997 (Joint Expert Technical Advisory
Committee on Antibiotic Resistance, 1999). In the early 1950s, antimicrobial agents
were introduced in animals after drugs were applied for human treatments (McEwen and
Fedorka-Cray, 2002).

The aims of antibiotics application to animals were to treat

unhealthy animals and control infection at therapeutic levels, to prevent diseases in
animals (prophylactic use), and to enhance feed efficiency and animal production at
growth promoting levels (Barton, 2000; McEwen and Fedorka-Cray, 2002).

The

phenomenon of growth promotion by antibiotics was first observed in the late 1940s, and
was termed “animal protein factor” and later as vitamin B12 (Jones and Ricke, 2003).
Further investigation revealed that enhancement of growth rate and feed efficiency was
noted when animals were administered fungal waste from antibiotic production for the
purpose nutrients and a direct growth promoting effect of residual antibiotic was
discovered (Prescott, 2006; Jones and Ricke, 2003).

Over a half-century, various

antibiotics have been added to feed for improving growth and production. During this
period, antibiotic uses for growth promotants have significantly increased in animal
operations, mainly in industrial farms (Barton, 2000). Antimicrobial agents registered for
23

use at sub-therapeutic levels are different around the world (World Health Organization,
1997; Joint Expert Technical Advisory Committee on Antibiotic Resistance, 1999). The
mode of action of antibiotics used to improve growth is not known with certainty
(Commission on Antimicrobial Feed Additives, 1997). However, the effects of these
agents are thought to act in several ways including on the beneficial bacteria in intestine,
causing pathogen death, decreasing the amount of microbial toxin, diminishing nutrient
utilization by microbes, synthesizing vitamins and other growth factors, increasing the
nutrient absorption by lowering the enterocyte epithelium thickness, decreasing turnover
of intestinal epithelium and reducing intestinal motility (Prescott and Baggot, 1993).
Antibiotic uses in animal operation also improve production and increase income benefits
(Cromwell, 2002), as well as decrease cost of animal products (Dupont and Steele, 1987).

Classification of Antibiotics
Antibiotics, small molecule compounds, are able to kill or impede microbial
growth when applied to an animal orally, intravenously, subcutaneously or
intramuscularly (Salyers and Whitt, 2002). Fungi and bacteria are recognized as sources
of many antibiotics, in which chemical processes are applied to induce greater activities
of antibiotics (Salyers and Whitt, 2002). Chemical properties and modes of action
distinguish antimicrobial agents. The classifications of drugs are described by different
principles, including the microbial target, chemical structure, and the susceptible
microbial ranges (Guardabassi and Courvalin, 2006). In this review, details of only the 3
drug classes used in this trial will be presented.

24

Tetracyclines
The tetracyclines were discovered in the 1940s and applied in animal production
in the early 1950s (Prescott, 2006). The action of the tetracycline family is to stop
microbial protein synthesis by blocking aminoacyl-tRNA binding to the ribosome
(Chopra and Roberts, 2001). Several reports demonstrate that tetracyclines can interact
with different binding sites such as the 30S ribosomal subunit, the 70S ribosomal protein
(Goldman et al., 1983), 16S rRNA conserved region (Rasmussen et al., 1991), and the
cytoplasmic membrane (Oliva and Chopra, 1992). Tetracyclines are broad-spectrum
drugs which act against various microorganisms, including Gram-positive, Gramnegative bacteria, mycoplasma, and rickettsiae (Roberts, 2003). In addition, in some
countries, including the United States, tetracyclines are applied to animal feeds for
enhancing growth. Streptomyces spp. produce several tetracycline derivatives such as
chlortetracycline,

oxytetracycline,

tetracycline,

demethylchortetracycline,

etc.

(Guardabassi and Courvalin, 2006). Tetracyclines are frequently provided to animals
(Guardabassi and Courvalin, 2006; Danish Integrated Antimicrobial Resistance
Monitoring and Research Program, 2004). Oxytetracycline, a member of tetracycline
class, is normally administrated to swine by ingestion (Pijpers et al., 1991).
In 1953, Shigella dysenteriae, a bacterium that causes bacterial dysentery, was the
first bacterium that demonstrated tetracycline resistance. Subsequently, the prevalence of
tetracycline resistant bacteria has been increasingly detected in many types of bacteria
(Roberts, 1996). Currently, tetracycline resistant microbes are widely distributed, thereby
narrowing the effectiveness of drugs to treat infections caused by bacteria (Jones et al.,
1992). Bacteria resistant to tetracyclines use the following mechanisms: 1) controlling
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entry of tetracycline into the microbial target sites by reducing uptake and activating
tetracycline efflux, 2) changing the ribosomal binding sites to block the attachment of this
drug and 3) inducing enzyme synthesis to inactivate tetracyclines (Speer et al., 1992).
Generally, a porin channel, which is encoded as OmpF genes and located on outer
membrane of Gram-negative, is a main entry site of tetracycline into bacterial cell. By
lowering expression of this gene, mutant bacteria express some resistance to tetracyclines
(Franklin and Snow, 1998).

The prevalence of tetracycline resistance and resistant

mechanisms has been continuously studied in E. coli (Miles et al., 2006; Karami et al.,
2006; Bryan et al., 2004), Salmonella spp.

(Frech and Schwarz, 1999; Frech and

Schwarz, 1998; Pasquali et al., 2005) and other types of bacteria (Dzierzanowska-Fangrat
et al., 2006; Bertrand et al., 2005; Malhotra-Kumar et al., 2005). Humans, animals, food
and the environments are significant sources of tetracycline resistant bacteria.
Presumably, non-pathogens from these sources pool antibiotic resistance genes (Roberts,
1996).

Aminoglycosides
Aminoglycoside was first discovered in 1944; after which, the agent was
chemically modified to produce more potent drug activity (Kotra et al., 2000).
Gentamicin, amikacin, streptomycin, kanamycin, neomycin and apramycin are members
of aminoglycoside class produced from Streptomyces and Micromonospora spp. The
drugs in this group are extensively applied to treat diseases in poultry, mammals, and
humans with the exception of apramycin, which is only used in animal treatments
(Guardabassi and Courvalin, 2006). Apramycin has been widely used in animal practice
since 1978.

However, the detection of apramycin resistance has been reported in
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Klebsiella pneumoniae and E. coli isolated from human sources (Johnson et al., 1995).
This finding, in contrast to a recent report by Phillips and coworker (2004), indicates that
the appearance of resistance gene transfer occurs between bacteria from humans and
animals. The effective action of aminoglycosides is to tightly attach to 30S ribosome
binding site and cluster 30S initiation complex (30S-mRNA-tRNA), thereby stopping
protein synthesis. Additionally, the attachment of this drug activates mRNA misreading
which result in lower protein synthesis (Guardabassi and Courvalin, 2006). The actions
of these drugs are broad spectrum, efficient against Gram-negative and Gram-positive
bacteria, and are less effective under anaerobic condition, i.e., inside the animal cell.
Therefore, these drugs may have limited ability to kill intracellular bacteria (Franklin and
Snow, 1998).
Bacterial resistance mechanisms to aminoglycosides include reducing access and
aggregation of the drug in the bacterial cell and producing several enzymes to modify and
inactivate

the

antibiotics

(Shaw

et

al.,

1993).

These

enzymes

include

phosphotransferases, acetyltransferases and adenyltransferases which change the
chemical properties of aminoglycosides, resulting in failure to access and target the
binding sites in bacteria (Smith and Baker, 2002). For an example, apramycin resistance
is associated with the enzyme of 3-N-aminoglycoside acetyltransferase type IV
[AAC(3)IV] and this enzyme also modifies tobramycin and gentamicin which are
normally used for infectious therapy in humans (Brau et al., 1984). Aminoglycoside
resistance such as apramycin resistance found in bacteria, including E. coli, Salmonella
spp. has been investigated in animal and human sources (Yates et al., 2004; Mathew et
al., 2003; Mathew et al., 1998; Chaslus-Dancla et al., 1991).
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Carbadox
Quinoxaline-di-N-oxides are broad range antibiotics, in which two derivatives,
carbadox and olaquindox, are commonly included in swine and bovine feeds (Beutin et
al., 1981). Carbadox is also recognized as a growth enhancer to improve weight gain and
increase feed utilization. However, the use of quinoxalines for promoting growth is
uncertain since the basic activity of these drugs, mostly carbadox, is to prevent pig
dysentery (Guardabassi and Courvalin, 2006).

The action of carbadox is to inhibit

deoxyribonucleic acid (DNA) synthesis, and then cause DNA damage in bacterial cell
(Suter et al., 1978). Carbadox resistant isolates, particularly among E. coli, have been
experimentally observed in pigs fed with this type of antibiotic as a feed additive
(Spanoghe and Pohl, 1987; Mathew et al., 1998). In the late 1980s, carbadox in animal
feeds was prohibited in Australia (Joint Expert Technical Advisory Committee on
Antibiotic Resistance, 1999) and in the 1990s, the use of olaquindox and carbadox were
also prohibited in the European Union (Burch, 2005) because of carcinogen concerns.

Antibiotic Resistance
The occurrence of antibiotic resistance reduces efficacy of antimicrobial agents
applied to treat or prevent diseases (Centers for Disease Control and Prevention, 2006).
In the 1960s, antibiotic resistance was detected in bacteria of the Enterobacteriaceae
family (Prescott, 2006).

Presumably, due to extended, incorrect and overuse of

antibiotics in human and animal therapy, these may lead to an increased antibiotic
resistance in bacteria, including foodborne pathogens (Bronzwaer et al., 2002; McEwen
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and Fedorka-Cray, 2002; Shea et al., 2004). Similarly, the extensive uses of antibiotics at
sub-therapeutic levels for long periods may potentially cause a crisis of antibiotic
resistance in microbes, possible transferred from animals to humans (Kelly et al., 2004;
Shea et al., 2004). Typically, sensitive bacteria may mutate to drug resistant strain, or
obtain antibiotic resistant encoded genes from other bacteria (Tenover, 2006).

Genetic Acquisition of Antibiotic Resistance
Related resistance genes have been detected in different types of many bacteria,
representing the transfer of resistant genes which is described as “horizontal transfer”
(Kazimierczak et al., 2006; Winokur et al., 2001; Shoemaker et al., 2001). The obtaining
of external genes, encoding resistance to a variety of antibiotic classes is expressed in
several phenotypes of antibiotic resistance (McDermott et al., 2003). The exchange of
resistant genes occurs in both non-pathogens and pathogens (Sorum and Sunde, 2001;
Swartz, 2002). The acquisition of genes by “vertical transfer” is through DNA mutation
and mutated genes are then transferred to following generations by sexual mechanisms
(Tenover, 2006) while “horizontal transfer” involves the integration of antibiotic encoded
genes to plasmid or transposons followed by transfer (Schwarz et al., 2006). Whatever
the mechanism of resistant mutation, the sensitive bacteria are killed, but resistant
bacteria live and grow (Tenover, 2006). Horizontal gene exchange involves the genetic
elements, including transposons, plasmids, gene cassettes, integrons and chromosomal
genomic islands which vary in structure, properties, size and spreading method (Hall,
1997; Herrero et al., 2006; Schwarz et al., 2006). Resistance to multiple antibiotics can
be obtained via a single genetic occurrence by integrating the resistant genes in mobile
elements (McDermott et al., 2003). Plasmids, or “the extra-chromosomal elements”, are
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basically found in bacteria and carry chemical agent resistance and antibiotic resistance
genes (Schwarz et al., 2006). Plasmids normally represent as vectors for other genetic
elements (Radstrom et al., 1994). Plasmids can transfer and integrate into plasmids
and/or chromosomal DNA of the other bacterial cells and then the encoded genes may
steadily replicate from new integrated plasmids and/or integrated chromosomal DNA
(Schwarz et al., 2006). Transposons which generally combine specifically and nonspecifically to vector and chromosomal DNA have been characterized by size and
structure. The smallest transposons consist of transposase genes which associate with
insertion and excision of the elements; however larger transposons frequently have one or
more additional antibiotic resistance genes (Schwarz et al., 2006). Gene cassettes contain
specific recombination sites, described as “59-base elements” (Hall et al., 1999), and
genes mainly encoding antibiotic resistance (Fluit and Schmitz, 1999). These elements
which express in both Gram-negative and Gram-positive bacteria are able to transfer by
site-specific integration in an integron since they lack “replication systems” or
“transposition systems” (Fluit and Schmitz, 1999; Schwarz et al., 2006). An integron
consists of a “site-specific integration system” that is able to capture and mobilize genes
that are set in gene cassettes (Hall and Collis, 1995) and these elements can obtain several
genes and express the integrated genes by providing the promoter (Stokes and Hall,
1989). The genetic elements exist in several different forms since integrated genes vary
in numbers and characteristics (Stokes and Hall, 1989).

Consequently, integrons

commonly demonstrate multidrug resistance genes because they carry several
distinguishable gene cassettes (Leverstein-van Hall et al., 2003). The basic structure of
an integron is composed of two conserved segments, defined as 5’ and 3’ conserved
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regions (Daly and Fanning, 2004; Levesque et al., 1995). The 5’ conserved region
contains the integrase gene; intIl, which is associated with gene cassette integration at a
specific site, the promoter; Pc, express the cassette genes (Schwarz et al., 2006; Collis
and Hall, 1995), and the attachment site; attI, responsible for gene cassette integration
(Daly and Fanning, 2004). The 3’ conserved region has several open reading frames
which include qacE∆1 gene, “a semi-functional derivative of the quaternary ammonium
compounds resistance gene qacE”, commonly related to sulfonamide resistance gene,
sul1 (Daly and Fanning, 2004). Reports reveal that integrons are widely detected in
clinical isolates (Levesque et al., 1995).

Several classes of integrons have been

identified, with the predominant interest in classes 1, 2 and 3 for antimicrobial resistance
spread (Ploy et al., 2000).
In general, the exchange of drug resistant genes between resistant and sensitive
bacteria occurs by three processes; transduction, conjugation, or transformation (Tenover,
2006; Wolska, 2003). For each of these processes, transposons may also enable transfer
and integration of resistance genes into the plasmids or chromosomal DNA (Tenover,
2006). Transduction process is facilitated by bacteriophage (Barbosa and Levy, 2000;
Schwarz et al., 2006), in which transferred DNA is packed, representing the vector for
transporting DNA into a recipient cell (Davison, 1999), where it can directly obtain new
phage elements (Schwarz et al., 2006). Transduction process may have less efficiency to
distribute resistance genes due to the limitation of DNA amounts packed into a vector and
specific receptors for phage binding on new host cell surface (Schwarz et al., 2006).
Conjugation, or “cell-contact-dependent DNA transfer mechanism” (Davison, 1999), is
associated with direct cell contact for the exchange of plasmids or chromosomal DNA
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(Barbosa and Levy, 2000). This method is recognized as important for DNA exchange
and spreading drug resistance genes (Barbosa and Levy, 2000; Schwarz et al., 2006).
Salyers and coworkers (1995) indicate that drug resistant genes contained in conjugative
plasmids and transposons are detected in both Gram-positive and Gram-negative
pathogens. Transformation is a process of transferring, obtaining, and integrating the
naked DNA into recipient cells (Schwarz et al., 2006; Davison, 1999). Generally, the
bacterial free DNA from cell lysis mechanism can be either degraded in the environment
or obtained by some bacteria (Schwarz et al., 2006).

Antibiotic Resistance Mechanisms
Bacteria are resistant to antibiotics by various mechanisms (Tenover, 2006),
which include changes in the bacterial cell wall/membrane to limit drug entry to target
sites, activation of efflux mechanism to move drugs out of the cell, mutation of the target
site, and synthesis of enzymes to modify or degrade the drugs (McDermott et al., 2003).
Porins of Gram-negative bacteria that limit the movement of antibiotic across the outer
membrane are an example of restriction entry of the antibiotic to its target. An additional
mechanism that can prevent antibiotics from reaching their target is efflux pumps in the
cytoplasmic membrane (Tenover, 2006). Modification processes are associated with
mutations of genes encoding target proteins.

For example, under the exposure of

antibiotics that target ribosomal binding site and stop protein synthesis, a bacterium may
alter an rRNA target site, thereby not allowing an antibiotic to bind (Schwarz et al.,
2006).

Hydrolyzation and adding chemical groups to antibiotics are examples of

antimicrobial agent inactivation (Schwarz et al., 2006). To destroy drug activity, some
enzymes can transfer acetyl, adenyl or phosphoric groups to specific targets of the
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antibiotics, meanwhile other enzymes, including β-lactamase, hydrolases and esterases,
are able to directly inactivate the drug molecules (Schwarz and Chaslus-Dancla, 2001).

Drug Resistant Salmonella
Antimicrobial resistance is present in Salmonella isolates from animals and
humans (Padungtod and Kaneene, 2006). Gebreyes and Altier (2002) noted that high
prevalence and diversity of multidrug resistance are observed in Salmonella.

The

extended use of antibiotics in animals results in the spread of multidrug resistant bacteria
(Daly et al., 2000). The appearance of resistance genes on plasmids is recognized as a
factor involved in the dissemination and stability of antibiotic resistance in Salmonella
Typhimurium (Gebreyes and Altier, 2002).

In the 1960s multidrug resistance was

reported in Salmonella (Watanabe and Fukasawa, 1961; Watanabe and Lyang, 1962;
Prescott, 2006). The resistance patterns of Salmonella related to public health concern
are frequently associated with specific phage types. One notable multidrug resistant
strain is Salmonella enterica subspecies enterica serovar Typhimurium definitive type
104 (DT104), basically known to be “pentaresistant”, expressing resistance to ampicillin,
chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline, indicated as the
“AmCmStSuTe resistance phenotype” (Gebreyes and Altier, 2002). The first recognition
of this Salmonella phage type was in the United Kingdom (Threlfall et al., 1996) and this
strain has been reported in many parts of the world (Glynn et al., 1998; Lai-King et al.,
1999; Baggesen et al., 2000; Wasyl et al., 2006) and from various host species including
food animals and pets (Wright et al., 2005; Gebreyes et al., 2006; and Guardabassi et al.,
2004) as well as from processed meat products (White et al., 2001). In the United States,

33

the prevalence of Salmonella Typhimurium DT104 increased approximately 33.4%
within 16 years (1980-1996) (Glynn et al., 1998) and, recently, these multidrug resistant
bacteria have become wide spread (Threlfall et al., 1997; Dechet et al., 2006).
Furthermore, the additional multidrug resistance patterns of Salmonella Typhimurium
have been investigated for phage types involving public health concern, i.e., DT193,
DT21, etc. (Gebreyes et al., 2004).

Alternatives to Antibiotics for Animal Growth and Health
The use of antibiotics in animal feeds is increasingly opposed by consumers,
thereby forcing livestock producers to treat and prevent Salmonella using alternative
methods (Gurtler et al., 2004). Probiotics and prebiotics have been reported to contribute
to protection or therapy for some diseases (Guarner and Malagelada, 2003). Probiotics,
defined as “live microorganisms”, beneficially affect health (Nomoto, 2005). The actions
of probiotics are unclear, but their roles are possibly to change gut pH, to induce
antimicrobial compounds in order to antagonize pathogens, to compete for pathogen
adherence and available nutrients, to activate immune cells and to produce lactase
enzyme (Parvez et al., 2006). Furthermore, Collington and coworkers (1990) observed
that feeding probiotics as an alternative to antibiotics affected the development of
digestive enzyme activities (including sucrase, alpha-D-glucohydrolase, and lactase: betaD-galactoside galactohydrolase and tripeptidase) prior to weaning in pigs. Prebiotics,
recognized as “non-digestible food fiber components”, promote animal health with the
activation of multiplication and roles of microflora in intestine (Nomoto, 2005). An
example of a prebiotic is mannanoligosaccharides (MOS), which possibly provide an
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alternative to some feed ingredients to increase growth rate in nursery pigs (Davis et al.,
2002). MOS may enhance growth by binding to bacterial cell walls in order to prevent
attachment to intestinal epithelium (Spring et al., 2000) or activate a direct antibody
response to enhance the immune system (Newman and Newman, 2001; O’Quinn et al.,
2001). Inclusion of MOS in feed before possibly increases feed utilization, thereby
promoting intestinal function (Burkey et al., 2004).
Spray dried porcine plasma (SDPP), identified as a common protein source
supplemented to early weaned pig diets in North America, promotes growth performance
and feed consumption in weaned pigs (Pierce et al., 2005; Van Dijk et al., 2002a). The
mode of action SDPP is uncertain, but it possibly increases appetite in small pigs (Ermer
et al., 1994). Furthermore, specific immunoglobulin proteins in SDPP may positively
increase growth performance (Owen et al., 1995). Providing SDPP to animals possibly
offers a protection against enteric pathogens (Bosi et al., 2004) and has been shown to
diminish enterotoxigenic E. coli K88 shedding in experimentally weaned pigs (OwusuAsiedu et al., 2003). Van Dijk and coworkers (2001) indicated that immunoglobulin G
and glycoprotein fractions of supplemented SDPP can prevent pathogen adherence which
results in the reduction of intestinal infection in post weaning pigs. Further studies
demonstrated that in-feed inclusion of SDPP in pigs can suppress basal immune
responses compared to those of pigs fed a control diet without SDPP (Touchette et al.,
2002), and maintain mucosal responses as well as enhance specific antibody defensive
system (Bosi et al., 2004). However, some research indicates that dietary SDPP does not
impact intestinal digestive enzyme functions including lactase, sucrase or maltase, small
intestinal morphology or disaccharidase activity in early weaned piglets reared under low
35

infection environment (Van Dijk et al., 2002b). Similarly, in-feed SDPP did not increase
survival of piglets challenged with pathogenic E. coli (Van Dijk et al., 2002a).

Egg Yolk Antibodies
Oral administration of egg yolk powder containing specific immunoglobulins as
passive immunization is an alternative way to prevent and treat intestinal infection
(Gurtler et al., 2004). After immunization of laying hens, specific immunoglobulins are
produced and transported to the hen egg yolk (Larsson and Carlander, 2003).
Immunoglobulin Y (IgY) antibodies mainly deposited in egg yolk, have a similar
function to IgG in mammals (Sharma, 1997). Annually, 280 eggs can be collected in a
chicken and 100-150 mg of IgY are obtained per yolk, resulting in approximately 40 g of
IgY produced from a single chicken (Mine and Kovacs-Nolan, 2002). Gassmann and
coworkers (1990) indicate that further advantages producing IgY by immunizing
chickens are the very low amount of antigen used to immunize the chicken, duration of
IgY production, simple, cheap, and fast method used to purify IgY, and no inflammatory
reactions.

Structure and Properties
Eggs natural components have no adverse effect on IgY (Larsson and Carlander,
2003). The basic structure of IgY consists of 2 heavy chains and 2 light chains with a
molecular mass of 180 kDa. Both the heavy and light chains contain variable region
genes (V), joining region genes (J) and multiple diversity segments (D) that are
rearranged by the mechanism of conventional V(D)J recombination. In order to generate
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a large diversity of antibody production, poultry use an additional process of DNA
recombination, or gene conversion (McCormack and Thompson, 1993). Each heavy
chain typically carries one variable and four constant region domains (Warr et al., 1995)
and no hinge region, whereas, IgG has three constant domains and a hinge region
(Morrison et al., 2002). The surface of the second and third constant domains of IgY
(CH2/CH3) in heavy chain is recognized by the receptors on developed chicken oocytes
necessary for immunoglobulin transport into chicken yolk (Morrison et al., 2002). Noll
and coworkers (1982) observed that principle structures of IgG are similar to those of IgY
which are that immunoglobulin molecules present in Y-shape with an angle of about 90
degrees between fragment antigen binding (Fab) sites with approximately 10 nm for one
Fab length. IgY do not trigger mammalian complement or activate mammalian Fc
receptors which may stimulate inflammatory response in the gastrointestinal tract
(Carlander et al., 2000). IgY is a more hydrophobic molecule than IgG (Davalos-Pantoja
et al., 2000).

Roles of Egg Yolk Antibodies
Yolk antibodies have been investigated for the protection of microbial infections
(Carlander et al., 2000). In bacterial disease, the roles of IgY are to neutralize toxins, to
enable opsonization, and to modulate the lysis of bacteria via compliment system. For
infection caused by viruses, IgY inhibit virus entry into healthy cells, and supports the
killing systems of immune cells (Keller and Stiehm, 2000). In vitro study of passive
immunization against Salmonella Enteritidis suggests that anti-fimbriae egg-yolk
antibodies possibly diminish bacterial attachment and penetration during the early stages
of infection in mice (Peralta et al., 1994). Similarly, anti-fimbriae antibodies from
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chicken egg yolk experimentally prevented the binding of E. coli K88+ to mucosal
receptors from the piglet intestine (Jin et al., 1998). Additionally, a study of adherence of
enterotoxigenic E. coli on intestinal epithelial surfaces in piglets by using scanning
electron microscopy demonstrate that E. coli colonized on the surface of intestinal
epithelium in control group, but no binding of bacteria was observed in piglets treated
with high-titer chicken egg yolk antibodies (Yogoyama et al., 1992). In vitro study of
chicken egg yolk antibody against Salmonella Typhimurium and Salmonella Enteritidis
demonstrate that the inhibition of Salmonella growth by anti-Salmonella yolk antibodies
was observed in non-solid medium.

Further study of antibody adherence activity

observed by using immunofluorescence and immunoelectron microscopy revealed that
anti-Salmonella antibodies were able to attach to the antigens present on the Salmonella
surface, which led changes of bacterial surface structures (Lee et al., 2002).

Potential Uses to Treat Bacterial Infection in Small Intestine
Oral supplementation of IgY has been used to treat gastrointestinal infectious
diseases, such as bovine and human rotaviruses, bovine coronavirus, Yersinia ruckeri,
enterotoxigenic Escherichia coli, Salmonella spp., Edwardsiella tarda, Staphylococcus,
and Pseudomonas (Mine and Kovacs-Nolan, 2002). After passive ingestion of yolk, the
antibodies interact with digestive environments that include a sharp reduction of pH and
proteolytic digestive enzymes. Such an environment may degrade or impact the activity
of the antibodies.

However, Schmidt and coworkers (1989) indicated that globulin

fractions or isolated antibodies were less resistant to acidic condition than antibodies in
protein rich solutions which included egg or yolk. In addition, in-feed inclusion of
additional egg white significantly revealed a protective effect on antibodies from yolk
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during the digestive process (Wiedemann et al., 1990). Ikemori and coworkers (1997)
also suggest that protein and lipid components naturally found in the yolk, may
encapsulate IgY molecules and protect them from degradation. Furthermore, IgY in yolk
are by design inherently resistant to digestive processes and may sufficiently offer
protection in the target sites of the small intestine. Chicken antibodies are resistant to
heat and possibly applied to prevent or to treat intestinal diseases in young animals or
humans (Gassmann et al., 1990). However, Chang and coworkers (1999) indicate that
under the stability tests with temperature from 70 to 80 °C, activity of IgY was reduced,
but with adding high levels of sucrose, maltose, glycerol, or 2% glycine, IgY were
efficiently protected.

Related Studies
Chicken egg antibodies can be supplemented to young animals for treatment of
intestinal infection diseases (Wiedemann et al., 1991; Marquardt, 2000). Currently, they
represent a potential alternative to antibiotic therapies (Girard et al., 2006; Van Nguyen et
al., 2006). Marquardt and coworkers (1999) obtained egg yolk antibodies from hens
immunized with fimbrial antigens from a strain of enterotoxigenic E. coli (ETEC) K88+
and given to newborn (3 day old) and early-weaned (21 day old) piglets challenged with
ETEC K88+. It was noted that the incidence of diarrhea was decreased in the 3-day-old
piglets one day after providing specific egg yolk antibodies. For protection in earlyweaned piglets, feeding egg yolk antibodies resulted in shorter durations of diarrhea,
increased weight gains and survival found in all pigs. This study indicates that piglets
administered specific egg yolk antibodies were protected against ETEC infections.

39

Further evidence of the beneficial effects of egg yolk antibodies is provided by
Yogoyama and coworkers (1998a), who studied specific chicken egg yolk antibody
efficiency to control salmonellosis in mice. Yolk antibodies provided to mice were
produced against outer membrane proteins (OMP), lipopolysaccharide (LPS) or flagella
(Fla) from Salmonella Typhimurium and Salmonella Enteritidis. Compared to control
group without antibody treatments, higher survival rates were observed in mice provided
the antibody treatments. The researchers suggested that mice fed egg yolk antibodies
specific for Salmonella OMP, LPS, and Fla could possibly be protected from
experimental salmonellosis. In another study, Yokoyama and coworker (1998b) provided
chicken egg yolk antibodies specific against Salmonella Typhimurium or Salmonella
Dublin to newborn Holstein calves. The results showed that oral supplementation of
antibodies provided dose-dependent protection against infections in both Salmonella
strains. All calves in control group were dead, but calves fed with low-titer antibodies
had approximately 40% mortality and calves obtained the highest concentration of
antibody showed clinical signs of fever and diarrhea without deaths within 7 to 10 days
after inoculation. It was concluded from these studies that specific egg yolk antibodies
against Salmonella Typhimurium or Salmonella Dublin exhibit the protection of
mortality from salmonellosis in young calves fed high doses of antibodies.
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Pigs, Housing, and Treatment Design
In two replicate trials, 132 weaned pigs (approximately 21 days old) which had
never been exposed to antibiotics were received from The University of Tennessee
Martin Swine Research Station, Martin, TN and transported to the Johnson Animal
Research and Teaching Unit (JARTU), The University of Tennessee, Knoxville, TN. For
this experiment, all pigs were housed and managed under properly controlled conditions
and all animal procedures and experimental protocols were approved by The University
of Tennessee Institutional Animal Care and Use Committee (IACUC).
Salmonella enterica serovar Typhimurium (798) 4232 (National Animal Disease
Center, Ames, Iowa) was used for the bacterial challenge. This strain was identified by a
nalidixic acid resistance marker (Ebner and Mathew, 2000; Cullen et al., 2002; Mathew
et al., 2002). Salmonella inocula were generated by culturing from stock on XLT4 agar
(Difco, Sparks, MD) containing 50 µg/ml of nalidixic acid (Sigma, St. Louis, MO) at
37°C overnight. The following day, Salmonella colonies were picked from plates and
grown in 2 flasks containing 200 ml Luria-Bertani (LB) Broth (10 g Bacto-tryptone, 5 g
yeast extract, 10 g NaCl / 1 liter H2O) and supplemented with 50 µg/ml of nalidixic acid
(Sigma, St. Louis, MO) for 18 h at 37°C in incubator. Before challenge, Salmonella
cultures from 2 flasks were mixed and the cell concentration in broth was obtained by
enumeration using serial dilution and XLT4 plus nalidixic acid (50 µg/ml) agar plating.
Salmonella with final concentration of 7.95×107 colony forming unit (CFU)/ml for the
first replicate trial and 1.90×108 CFU/ml for the second replicate trial were used for oral
(3 ml) and intranasal (2 ml per nostril) challenge to all pigs on day 7 of trial.
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Pigs were randomly assigned to separate treatment rooms with controlled lighting
regimen (12 h of light and 12 h of dark). The treatments are shown in Table 1 (All tables
are located in the Appendix). Feed treatments were given to weaned pigs on day 3 of
trial. All treatment pigs had feed and water access ad libitum. Feed and treatment dietary
compositions were formulated according to the recommendations of National Research
Council Nutrient Requirements of Swine (1998) for the starter phase I for 14 days, starter
phase II after 14 days until pigs reached 20 kg and feeder/grower phase III after 20 kg
until 35 kg, as listed in Table 2, 3, and 4, respectively.

After reaching 35 kg

(approximated day 35), pigs in all treatment groups were continuously fed a control diet
for the rest of the study.

Egg yolk powder containing Salmonella antibodies was

provided by R. R. Marquardt and C. M. Nyachoti at University of Manitoba, Winnipeg,
Manitoba, Canada. Briefly, the procedure for producing specific egg yolk antibodies
involves immunizing laying hens with antigens isolated from Salmonella Typhimurium,
including lipopolysaccharide, fimbrial proteins, and outer membrane proteins.
Immunized chicken eggs were cracked and egg yolks were separated from whole eggs by
straining. After removing yolks from egg whites, egg yolks were filtered to clear the rest
of egg white and transferred into a funnel attached with filter paper to collect the yolk
contents. The yolk contents were adjusted to a pH of 5.0 by diluting (1:9, v/v) with
acidified double distilled water and kept frozen at -20°C for 24 h. On the following day,
yolk contents were thawed and centrifuged at 10000×g for 30 minutes at 15°C. The
supernatant liquid was filtered twice with filter paper (Marquardt et al., 1999). The egg
yolk antibody powder was obtained by freeze-drying via a rapid vacuum freezing process
and then stored at 4°C until shipping.
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In each treatment room, pigs were raised in nursery crates (4’x 4’) for 3 weeks,
and subsequently, moved to finishing pens (8’ x 8’).

Biosecurity regulations were

followed for the whole period of the study. Cleanliness and sanitation in all rooms were
maintained prior to the study and throughout the study. The pen and floor in each room
were cleaned 3 times per week. Separate feed containers and scoops were used for each
room. Disposable coveralls (Fisher Scientific, Suwanee, GA), plastic boots (Nasco, Ft
Atkinson, WI), and latex gloves (Fisher Scientific, Pittsburgh, PA) were used during
cleaning, feeding and collecting samples from pigs. Coveralls and gloves were changed
between rooms. Before entry and after exiting each room, personnel used footbaths
containing chlorhexidine diacetate disinfectant (Nolvasan® solution; Fort Dodge Animal
Health, Fort Dodge, IA). All pigs were transported to The University of Tennessee,
Plateau Research and Education Center, Crossville, TN on day 89 of the experiment.
Pigs were housed in concrete pens, which were in a conventional swine facility.

Sampling Plan and Bacterial Analysis
For each pig, a fecal sample was taken from the rectum by using a sterile swab
(Fisherbrand Dacron, Houston, TX) prior to treatment application (day 0 of the
experiment), before challenge with the pathogenic Salmonella strain (day 7) and on days
8, 12, 14, 21, 28, 58, 88 and 118 for the isolation of Salmonella Typhimurium and E. coli.
Each sample swab was kept in an individual sterile glass tube (16x150 mm; Fisher
Scientific, Pittsburgh, PA) on ice and then transported to the laboratory for bacterial
analysis.
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After samples were brought to the laboratory, each fecal swab was streaked onto
individual lactose MacConkey agar (Difco, Sparks, MD) and all inoculated plates were
placed in the incubator for 24 h at 37°C for growing of E. coli. After streaking, the tip of
the same swab was cut and placed in 2 ml of Nutrient Broth (Becton Dickinson, Sparks,
MD), and then broth was mixed using vortex (VORTEX-GENIE™, Scientific industries,
Inc., Bohemia, NY). To enrich for Salmonella Typhimurium, the swab tip and 1 ml of
broth were transferred to a stomacher bag filled with 80 ml of tetrathionate broth (Difco)
and this bag was completely sealed, then, incubated at 42°C for 24 h. On the following
day, Salmonella tetrathionate culture was streaked onto XLT4 agar containing 50 µg/ml
nalidixic acid using a wire loop and all inoculated plates were placed in the incubator for
24 h at 37°C.
Four individual colonies for each bacteria type isolated from each sample were
analyzed for antibiotic resistance. Microbial shedding data were generated based on
determination of E. coli and Salmonella-positive samples.

Minimum Inhibitory Concentration Analysis
A total of 4,763 E. coli colonies and 2,139 Salmonella Typhimurium colonies
from fecal samples were analyzed for resistance to apramycin sulfate (Sigma, St. Louis,
MO), tetracycline (Sigma), and carbadox (Trek Diagnostic Systems, Inc., Westlake, OH)
via the minimum inhibitory concentration (MIC) broth dilution method (National
Committee for Clinical Laboratory Standard, 2002). Briefly, each E. coli and Salmonella
Typhimurium isolate cultured on individual MacConkey agar and XLT4 agar,
respectively, was picked using a wire loop and transferred to a sterile glass tube (16 x 150
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mm; Fisher Scientific, Pittsburgh, PA) filled with 5 ml of Mueller-Hinton II cationadjusted Broth (Becton, Dickinson and Company, Sparks, MD). Glass tubes containing
inoculated broth were incubated with shaking at 37°C. The cell concentration adjusted to
0.5 McFarland units (108 CFU/ml) (National Committee for Clinical Laboratory
Standards, 2002) by colorimeter (BioMerieux Vitex, Inc., Hazelwood, MO). For each
bacterial isolate sample, when the culture concentration was appropriately adjusted, 25.3
µl of prepared bacterial culture was added to 2.5 ml of diluted mixture of Mueller-Hinton
II cation-adjusted Broth and sterile water at a ratio of 1:10. The mixture (50 µl) of the
diluted Mueller-Hinton II cation-adjusted Broth and adjusted bacterial culture was added
to each well within a column of microtiter plate for antibiotic resistance analysis. At the
end, mixed bacteria concentration was approximately 5 x 105 CFU/ml (National
Committee for Clinical Laboratory Standards, 2002).
For each microtiter plate used for the MIC analysis, the first to the eleventh
columns were used for the bacterial sample analysis and the twelfth column was set for
the control bacteria (American Type Culture Collection # 25922 E. coli; Salmonella
Typhimurium (798) 4232, USDA, Animal Disease Control Center, Ames, Iowa).
Apramycin and tetracycline microtiter plates were prepared in the laboratory by
producing two-fold serial dilutions from 0 to 128 µg/ml in all columns. Carbadox
microtiter plates were prepared for the same serial dilutions (Trek Diagnostic Systems,
Inc., Westlake, OH) and freeze-dried and sealed for shipping. At room temperature, 50
µl of diluted bacterial cultures were added to each well of the antibiotic microtiter plates,
then covered with Para film (American National Can™, Menasha, WI) and incubated for
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18-22 h at 37°C. Antibiotic resistance was determined by observing bacterial growth.
The lowest concentration of antibiotic that the turbidity or a deposited spot of cells was
not detected in the well was recorded as minimum inhibitory concentration (MIC). The
MIC breakpoints for each antibiotic test in both E. coli and Salmonella Typhimurium are
presented in Table 5 (Danish Integrated Antimicrobial Resistance Monitoring and
Research Program, 1999; National Antimicrobial Resistance Monitoring System-Enteric
Bacteria, 2001; National Committee for Clinical Laboratory Standards. 2002).

Weight, Rectal Temperature Measurements and Blood Collection
On days 0, 7, 8, 12, 14, 28, 58, and 88 of the experiment, pigs were weighed on a
digital scale for performance analysis.

Rectal temperatures of twelve pigs in two

replicate trials randomly chosen in each treatment were monitored by digital thermometer
(MABIS Healthcare Inc., Lake Forest, IL) and blood samples were taken from those
same pigs for immunological analysis on days 0, 7, 8, 12, 14 and 28. Eight milliliters of
blood were withdrawn from the jugular vein using an 18-gauge 1.5 inch needle
(Sherwood Medical Company, St. Louis, MO) attached to a vacuum tube syringe filled
with glass beads (Sarstedt, Inc., Newton, NC), after which approximately 2 ml of blood
was transferred to a small sterile tube coated with EDTA, anti-coagulant,
(Vacutainer®PLUS, Franklin Lakes, NJ) for white blood cell analysis (Vet Count IIIB,
Mallinckrodt, Phillipsburg, NJ). The remainder of the blood was kept in vacuum tube
syringes. All blood samples were placed on ice for transport to the laboratory. Serum
was separated from blood samples in the vacuum tubes by the centrifugation at 260 × g
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for 15 minutes and each serum sample was approximately divided in half and saved in 3
Eppendorf microcentrifuge tubes (Fisher Scientific, Pittsburgh, PA). Serum samples
were kept in the freezer at -20 ºC for later analysis of swine interleukin-1β and porcine
Salmonella antibody concentrations.

Swine Interleukin-1β Analysis
Serum concentration of interleukin-1β (IL-1β) was analyzed using a
commercially available Enzyme Linked Immuno-Sorbent Assay kit (ELISA kit) specific
for porcine IL-1β (Biosource International Inc., Camarillo, CA).

Analyses were

conducted as described by the manufacturer with the minimum dose sensitivity of <15
pg/ml. A monoclonal antibody specific for IL-1β was coated onto the wells of 96-well
microtiter plate by the manufacturer. The standard curve with range from 0 to 2500
pg/ml was generated by adding 100 µl of standards to microtiter wells and adding
standard diluent buffer to the well set for 0 pg/ml. Wells reserved for the Chromogen
Substrate blank were left empty. For each well reserved for swine serum sample, 50 µl
of standard diluent buffer were added followed by 50 µl of sample for the dilution of 1:2,
then the plate was tapped gently on the side to mix the solution, covered with a plate
cover and incubated for 2 h at 37°C.

After incubation, solution in the wells was

thoroughly aspirated and discarded. The plate was washed 4 times as follows. One
hundred microliters of Biotinylated Polyclonal Anti-IL-1β (Biotin Conjugate) solution
were added into each well except the well reserved for the Chromogen Substrate blank,
and then the plate was tapped on the side to mix, covered with plate cover and incubated
for 1 h at room temperature.

Following incubation, the solution in the wells was
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thoroughly aspirated and discarded and the plate was washed. One hundred microliters
of Streptavidin-Peroxidase HRP working solution were added to each well except the
wells for the Chromogen blank, and then the plate was covered and incubated for 30
minutes at room temperature. The solution in the wells was thoroughly aspirated and
discarded and the plate was washed. At each of above steps, the plate was completely
washed 4 times by wash buffer. One hundred microliters of Stabilized Chromogen
substrate were added to each well. The plate was incubated for 20 minutes at room
temperature in the dark, and then 100 µl of stop solution were added to each well, and the
plate was gently tapped to mix. The solution in the wells was read against a Chromogen
substrate blank, which included 100 µl each of Stabilized Chromogen substrate and stop
solution at 450 nm by microplate reader (BioTek Instruments, Inc., Winooski, VT). The
plate was read within 2 h after adding the stop solution. The results of swine IL-1β
concentration were generated by reading optical density values of samples against
standard concentration and then multiplied by 2.

Porcine Salmonella Antibody Analysis
Serum concentration of Salmonella antibody was analyzed using a commercial
ELISA kit specific for porcine Salmonella antibody (IDEXX Laboratory, Westbrook,
ME).

Ninety-six well microtiter plates were coated with Salmonella antigen

(lipopolysaccharide antigen) at the manufacturer. Serum samples used for this procedure
were diluted twenty-fold (1:20) by mixing 15 µl of sample and 285 µl of sample diluent.
One hundred microliters each of undiluted negative control, undiluted positive control,
and diluted sample were added into the appropriate wells and incubated at room
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temperature for 30 minutes. The solution was discarded from the wells and the plate was
washed. After washing, 100 µl of Anti-Porcine: Horseradish Peroxidase Conjugate was
added into each well, after which plates were incubated for 30 minutes at room
temperature. Unbound conjugate was aspirated and the plate was washed. One hundred
microliters of TMB substrate solution was added in each well and incubated at room
temperature for 15 minutes. Following incubation, 100 µl of stop solution were added
into each well to stop the reaction. The absorbance values were measured related to the
blank with air and recorded in absorbance values at 650 nm. The presence of Salmonella
antibody in the serum sample is interpreted by relating absorbance values at 650 nm of
unknown sample to the positive control mean by calculating the sample to positive
control (S/P) ratio as shown in following formulation:
S/P ratio = Absorbance of sample read at 650 nm – Average negative control
Average positive control – Average negative control

Statistical Design and Analysis
The statistical model for growth performance, immunological data, shedding and
antibiotic

resistance

(tetracycline,

apramycin,

and

carbadox)

for

Salmonella

Typhimurium and E. coli consisted of a randomized block design with replication and
repeated measures with individual pig as the experimental unit, and blocking on trial
replications. Data were analyzed using the Mixed Procedure (SAS, 2002) to determine
the effects of treatments, days, and interactions of treatment by day. Least squares means
were analyzed and compared using least significant difference at P = 0.05. Shedding and
antibiotic resistance data were converted to binary indicators (i.e., if bacterial numbers
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were > 0 then = 1, otherwise = 0 for shedding analysis, and if MIC of tetracycline was
≥16 then = 1; otherwise = 0 for resistance analysis). The resistance threshold MIC was
different for each antibiotic. Correlations among Salmonella shedding, growth, rectal
temperature and immunological data were analyzed using Proc CORR (SAS, 2002).
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Bacterial Shedding
Salmonella Typhimurium were detected from pigs in all groups 24 h after they
were challenged (Table 6).

The percentage of pigs shedding Salmonella across all

treatments was highest on day 8 with declining levels between day 12 and day 118 of the
experiment (P<0.05). Significant treatment effects were noted (P<0.0001). Throughout
the study period, pig groups receiving the antibiotics apramycin, carbadox, and
oxytetracycline, showed a lower incidence of Salmonella shedding compared to pigs in
non-antibiotic groups and the control group (P<0.05). There were no differences in pigs
shedding Salmonella across all experimental days among groups that received egg yolk
powder containing ASEYA, egg yolk powder lacking ASEYA, or spray dried porcine
plasma compared to those receiving control diets.
All pigs were observed to shed E. coli at the beginning of the study and before
treatments were applied. A high percentage of pigs also shed this organism throughout
the period of the study (Table 7). Slightly decreased percentages of pigs shedding E. coli
across all treatments were noted on days 21, 58, and 118 of the experiment compared to
those observed from day 0 to day 12 of the experiment (P<0.05).

There were no

differences in the overall treatment effects across all days on pig shedding E. coli;
however, treatment × day interactions were noted (P<0.0001).

Bacterial Antibiotic Resistance
Less than seven percent of 2,139 Salmonella Typhimurium isolates were found to
be resistant to tetracycline, apramycin, and carbadox.
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On day 0 and day 7 of the

experiment, no Salmonella in any group were available for resistance measurements.
Resistance to tetracycline was only noted in Salmonella from pigs fed with diets
containing oxytetracycline.

However, Salmonella from pigs fed apramycin did not

demonstrate resistance to apramycin. Apramycin resistance was noted in a few isolates
from pigs fed spray dried plasma, although no significant treatment effects were noted.
Salmonella resistant to carbadox were noted in all treatment groups except for pigs fed
with egg yolk powder containing ASEYA. However, the dietary treatments did not affect
the percentages of Salmonella Typhimurium isolates resistant to any of the test
antibiotics.
Escherichia coli isolated from pig fecal samples were resistant to tetracycline,
apramycin, and carbadox (Tables 8-10). Treatment effects, day effects, and treatment ×
day interaction effects were noted. A significant percentage of E. coli was resistant to
tetracycline at the beginning of the experiment (Table 8). On day 12, the average
percentage of isolates resistant to tetracycline from all groups declined from that
observed on days 0, 7, and 8 (P<0.05). The lower percentages of tetracycline resistant
isolates persisted from day 12 to day 118. Across all days, the highest percentage of
tetracycline resistant E. coli was noted in pigs fed oxytetracycline (P<0.05). However,
the lowest percentage of tetracycline resistant E. coli was noted in pigs fed egg yolk
powder containing ASEYA (P<0.05). The percentages of tetracycline resistant E. coli
from pigs fed egg yolk powder lacking ASEYA and SDPP were lower than those from
pigs fed oxytetracycline (P<0.05), but indistinguishable from those from pigs fed control
diets or apramycin and carbadox. Similarly, across all days, the highest percentages of
apramycin resistant E. coli were observed in pigs fed apramycin (P<0.05) (Table 9). In
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that group, higher percentages of apramycin resistant E. coli were noted beginning on day
7, and remained higher in that group until day 21, compared to pigs fed other diets,
including egg yolk powder containing ASEYA, egg yolk powder lacking ASEYA, SDPP,
oxytetracycline, and control diets. However, two weeks after withdrawal of apramycin
(on day 28 of the experiment), the percentages of E. coli resistant to apramycin decreased
by 50% compared to day 21, and steadily declined until the end of the experiment.
Greater percentages of carbadox resistant E. coli were noted from pigs fed carbadox
compared to pigs in the control group, pigs fed egg yolk powder containing ASEYA and
pigs fed egg yolk powder lacking ASEYA (P<0.05) (Table 10). On day 28 and day 58 of
the experiment, higher percentages of E. coli resistant to carbodox were observed in the
pigs fed with carbadox compared to pigs fed egg yolk powder with ASEYA, egg yolk
powder without ASEYA, SDPP, oxytetracycline, and control diets.

Growth Performance
No treatment effects were observed for body weight or weight gain throughout the
course of the study (Table 11). However, day effects (P<0.0001) and day × treatment
effects (P<0.01) were noted. The body weights of pigs increased from the beginning to
the end of the study (P<0.05) for all treatments. On day 14 and 21 of trial, pigs fed
control diets had lower body weights compared to pigs fed apramycin and carbadox. On
day 28 of trial, lower body weights were observed in pigs fed control diets compared to
pigs fed apramycin and carbadox, and SDPP. On day 58 of trial, body weights of pigs
fed apramycin and carbadox, oxytetracycline, and SDPP were greater than body weights
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of pigs fed control diets. The body weights of pigs fed egg yolk powder containing
ASEYA were not different from pigs fed control diets on days 0, 7, 8, 12, 14, 21, 28, 58
and 88 of the experiment.

Rectal Temperature
Treatment effects (P<0.05), day effects (P<0.0001) and day × treatment effects
(P<0.0001) were noted for rectal temperatures (Table 12). Mean rectal temperatures
increased (P<0.05) across all treatment groups one day following challenge with
Salmonella Typhimurium. Decreased rectal temperatures were observed by day 12 (5
days post-challenge) and maintained through day 28 of trial. Overall, pigs fed diets with
oxytetracycline had significantly lower rectal temperatures compared to pigs fed spray
dried porcine plasma and egg yolk powder containing ASEYA (P<0.05), but were not
statistically different from pigs fed apramycin and carbadox, egg yolk powder lacking
ASEYA, or the control diet.

Immunological Values
White Blood Cell Counts
White blood cell counts of pigs across all diets were variable over the course of
the study (Table 13). No treatment effects on the numbers of white blood cells were
observed. However, day effects (P<0.0001) and day × treatment effects (P<0.01) were
noted for white blood cell counts. The numbers of white blood cells of pigs across all
groups were increased from day 7 to day 28 compared to those at the initiation of the
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experiment and were highest (P<0.05) 7 days after challenge with Salmonella
Typhimurium, then dropped to pre-challenge levels (day 7) approximately 2 weeks
following the challenge (day 21 of the experiment). On day 14 of trial, when the greatest
levels of white blood cell were reached, pigs fed control diet, egg yolk powder containing
ASEYA, egg yolk powder lacking ASEYA, and SDPP had significantly higher numbers
of white blood cells compared to pigs fed apramycin and oxytetracycline.

Porcine Salmonella Antibody
Salmonella antibody responses of pigs as indicated by the S/P ratio did not differ
among the dietary treatments (Table 14); however, day effects were detected (P<0.0001),
indicating that the porcine Salmonella antibody varied over time. The levels of antiSalmonella antibody of pigs across all groups increased beginning on day 14 and
continued to increase through day 28, or 3 weeks after they were challenged (P<0.05).

Swine Interleukin-1β
Serum IL-1β concentrations were not detected in most pigs regardless of
treatments during the course of the study. However, five pigs in the first replicate trial
had very low IL-1β responses. These included a pig fed oxytetracycline on day 12 (5.33
pg/ml), 2 pigs fed egg yolk powder containing ASEYA on day 12 (3.67 and 4.69 pg/ml),
a pig fed control diet on day 21 (3.74 pg/ml) and a pig fed control diet on day 28 (2.97
pg/ml). These 5 pigs also shed Salmonella Typhimurium.
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Relationships among Salmonella Shedding, Growth Performance,
Rectal Temperature and Immunological Values
The correlations among all variables were evaluated from day 0 to day 28 of the
experiment. More specifically, Salmonella shedding was unrelated to body weight, rectal
temperature, porcine Salmonella antibody, white blood cell counts, or swine IL-1β
concentration. In addition, body weights were not correlated to rectal temperature, or
immunological variables, such as IL-1β concentrations, white blood cell counts or
antibody levels.

Rectal temperatures also were not related to porcine Salmonella

antibody levels, white blood cell counts, and swine IL-1β concentrations.
immunological values, no relationships were observed in this analysis.
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Among

PART V. DISCUSSION
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The present study investigated the effects of in-feed egg yolk powder containing
specific antibodies against lipopolysaccharide, fimbrial proteins, and outer membrane
protein antigens isolated from Salmonella Typhimurium on bacterial colonization,
bacterial

antibiotic

resistance,

growth

performance,

rectal

temperature

and

immunological response in weaned pigs challenged with Salmonella Typhimurium.

Bacterial Shedding
Salmonella Typhimurium were not detected in pigs at the initiation of the
experiment and prior to inoculation with Salmonella Typhimurium, indicating that pigs
were likely free of this organism and that their health status was maintained during
shipping and holding prior to the initiation of the experiments. Salmonella Typhimurium
were detected in pig fecal samples 24 h after they were challenged orally and
intranasally. The relatively short time between inoculation with the challenge organism
and detection in the feces may be explained by the ability of Salmonella Typhimurium to
invade the internal organs, including tonsils, lung, and intestinal tract, and rapidly
disseminate through the lymph system, ultimately reaching the ileocolic lymph nodes,
and becoming present in the feces (Fedorka-Cray et al., 1995; Wood et al., 1989).
The present study indicates a lower incidence of Salmonella Typhimurium
shedding in pigs fed antibiotics, including oxytetracycline, apramycin, and carbadox.
These findings support the results of earlier studies in our laboratory, in which pigs
supplemented with apramycin and oxytetracycline had lower Salmonella shedding (Ebner
and Mathew, 2000).

Additionally, another study, focusing on the influence of

oxytetracycline on colonization of Salmonella Typhimurium in animals, found that use of
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oxytetracycline and neomycin resulted in a decrease in the percentage of pigs carrying
Salmonella Typhimurium (Evangelisti et al., 1975).
In contrast to the use of antibiotics, our results indicate that in-feed inclusion of
egg yolk powder containing specific antibodies is not effective in reducing shedding of
Salmonella Typhimurium by weaned pigs. The incidence of Salmonella shedding in our
study is similar to that of a study by Letellier and coworkers (1999), indicating that
feeding specific egg yolk antibodies against Salmonella Typhimurium did not diminish
colonization of this bacterium in mesenteric lymph nodes and feces in early weaned pigs
(12 days old). This is in contrast to the findings that such products can help reduce
enterotoxigenic E. coli in pigs (Imberechts et al., 1997: Owusu-Asiedu et al., 2003). We
suspect that the invasive nature of Salmonella Typhimurium may result in a systemic
infection, whereby organisms bypass the gut and move through vascular and/or lymphatic
routes directly into colon, thus contaminating feces just prior to excretion. This possible
mechanism of natural Salmonella infection may be an obstacle to the potential effects of
in-feed antibodies, as noted by Jin and coworkers (1998) that such egg yolk products
introduce specific antibodies to neutralize bacterial surfaces and inhibit adherence of
bacterial antigens to the mucosal target sites. Therefore, naturally invasive Salmonella
would differ from intestinal E. coli, including enterotoxigenic forms, which do not invade
peripheral tissues or cause systemic infections. Organisms, such as E. coli, would likely
be affected to a greater degree by specific egg yolk antibodies, directly providing
resistance to bacterial attachment (Yokoyama et al., 1992). An additional explanation for
the lack of effect of ASEYA is that an alteration of immunoglobulin (IgY) may have
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occurred during digestion in the alimentary tract of the pig, thereby resulting in
unsuccessful recognition of Salmonella (Letellier et al., 1999).
We also observed that the percentage of Salmonella shedding in pigs fed SDPP
was not different from pigs fed the control diet. Similarly, Van Dijk and coworkers
(2002) reported that fecal shedding of pathogenic E. coli O139:K82 detected from 19day-old weaned pigs fed 8% SDPP and inoculated with E. coli O139:K82 did not differ
from weaned pigs fed control diets.
In our study, pigs across all treatment groups had an approximately 60% decrease
in Salmonella shedding 51 days post-inoculation compared to those one day postinoculation. Inexplicitly, on day 88 of trial, Salmonella shedding across all treatments
slightly increased.
In our study, Salmonella Typhimurium bacteria were detected from day 8 to day
118 of the experiment or from 1 day to 111 days after challenge. A previous study in our
lab reported that pigs shed Salmonella until 64 days post-inoculation (Cullen et al., 2002).
This indicates that the recent study shows longer shedding duration. In our study, pigs in
all groups also shed E. coli from day 0 to day 118 of the experiment because E. coli
bacteria are commonly found in the intestinal tract of animals. Even though pigs were
transported to a conventional-type facility on day 89 of the experiment before samples
were collected on day 118, no effects on Salmonella shedding were observed.

Antibiotic Resistance
In our study, antibiotic resistance of E. coli and Salmonella Typhimurium were
analyzed via a minimum inhibitory concentration (MIC) broth dilution method.
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A

significant number of E. coli isolates demonstrated resistance to the test antibiotics,
whereas far fewer Salmonella demonstrated resistance to those same antibiotics. Our
results agree with those of Edrington et al. (2001), who reported that the increased
prevalence of antimicrobial resistant Salmonella was not detected in market swine
supplemented with carbadox and apramycin. This may be due to the fact that Salmonella
may not be exposed to a sufficient degree to produce resistant phenotypes in the gut
lumen. Therefore, the organisms did not adapt to the antibiotics, or they did not have
adequate residence time in the gut to acquire antibiotic resistance because they are highly
invasive (Jensen et al., 1998). Additionally, Spanoghe and Pohl (1987) indicate that
Salmonella have a poor ability to obtain carbadox resistance from other sources.
We observed that a high percentage of E. coli isolated in this study was resistant
to tetracycline prior to application of oxytetracycline. One possible reason is that pigs
may receive resistant organisms from other sources, such as the environment in which
pigs were placed before weaning or during moving to the experimental study unit (Hinton
et al., 1985). Langlois and coworkers (1988) also observed that pigs in the weanling
stage obtained from a farm, which was not exposed to antibiotics, had a high percentage
of fecal coliforms resistant to tetracycline compared to pigs at other growth stages, which
came from the same farm. This may indicate that animal age is a possible factor in
presence of resistant isolates.
Our results illustrate that feeding apramycin had the most pronounced effect on
the development of apramycin resistance. Similarly, Kim and coworkers (2005) reported
a high percentage of apramycin resistant non-pathogenic E. coli in piglets supplemented
with apramycin. This may support the findings of Gellin et al. (1989), who noted that
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feeding sub-therapeutic and therapeutic levels of antibiotic to pigs results in a high
proportion of antibiotic resistance in fecal bacteria. Dawson and coworkers (1984) also
indicated an increase in drug resistance may be impacted by other factors which include
“livestock history”, “cross-contamination” and “farm environment”.
Our antibiotic resistance results demonstrate that in-feed antibiotics impact
naturally occurring E. coli, which reside in pig intestinal tract, and then develop
resistance to antibiotics. Tetracycline resistant E. coli bacteria were detected across all
treatments in a high proportion of isolates (60-88 %) from day 0 to day 118 of the
experiment. The lowest percentage of tetracycline resistant E. coli was observed across
all groups on day 58 of the experiment. These results indicate that tetracycline resistant
E. coli were persistent in the intestine for a long duration.
In contrast to tetracycline resistance, E. coli isolated from pigs fed apramycin
were resistant to apramycin 4 days after treatment was applied but not before. Over 80%
of apramycin resistant E. coli isolates were observed from day 8 to day 21 of trial. The
percentage of apramycin resistant E. coli was dropped by half after approximately 2
weeks after apramycin was withdrawn from pig feed. Less than 13% apramycin resistant
E. coli were observed on days 58, 88, and 118 of trial. These observations indicate that
apramycin resistant E. coli quickly decreased after drug was withdrawn.
The appearance of carbadox resistant E. coli was observed approximately 2 weeks
after carbadox was used in the feed (day 28 of trial). Carbadox resistant E. coli isolates
were slightly detected approximately 53 days after carbadox was removed (day 88 of
trial). These results indicate that E. coli bacteria are resistant to carbadox when they are
under exposure to this drug.

Kim and coworkers (2005) also indicated that non88

pathogenic E. coli isolated from pigs is “drug-dependent” as they observed that piglets
supplemented with apramycin, carbadox, and chlortetracycline had an increase in
antibiotic resistant non-pathogenic E. coli in response to those three antibiotics.
The present study shows that feeding of egg yolk powder containing ASEYA did
not affect the prevalence of antibiotic resistance of either Salmonella Typhimurium or E.
coli isolates. Some researchers propose that chicken egg yolk antibodies could be used as
an alternative to antibiotics (Wiedemann et al., 1991; Girard et al., 2006; Larsson and
Carlander, 2003).

Growth Performance and Health
In this study, growth performance of pigs was measured in terms of body weight
over the course of study. Body weights across all days were not different among weaned
pigs challenged with Salmonella Typhimurium fed any of the diets, including the diet
containing egg yolk powder with Salmonella antibodies. Pig body weights increased
over time in all groups, as expected. Differences in growth rates also were not observed
in a separate study involving 10 day old weaned pigs challenged with F18
enterotoxigenic E. coli and fed dietary spray dried animal plasma, spray dried porcine
plasma, and chicken egg yolk antibodies containing specific antibodies or egg-yolk
powder lacking specific antibodies from day 0 to 14 post-weaning (Owusu-Asiedu et al.,
2002). In contrast, Yokoyama and coworkers (1997) reported greater weight gains in
weaned pigs at 28-days of age inoculated with virulent F18+ E. coli and supplemented
with anti-F18 fimbriae egg yolk antibodies at highest level (1:50).

This research

suggested that feeding egg yolk antibodies specific to F18 fimbriae could efficiently
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diminish infection severity, thereby resulting in less weight loss after challenge. Also in
contrast to our results, Ding and coworkers (2006a) observed that after inoculation with
K88 E. coli, piglets supplemented with olaquindox and cyadox, derivatives of carbadox,
showed improved growth performance, average daily gain and feed conversion ratio. A
study also indicated that the greatest average growth rates were observed in calves treated
with oxytetracycline after inoculation of Salmonella Typhimurium (Remillard et al.,
1981).
Although final body weights and mean weights did not differ among treatments,
this may be due to the length of time each diet treatment was applied. Therefore, we
evaluated body weights at each time period. Our results indicate that dietary treatments
differently affect body weights at each time point. In our study, we observed that pigs
fed apramycin and carbadox had higher body weights compared to pigs fed the control
diets on days 14, 21, 28 and 58 of trial. Similarly, pigs fed oxytetracycline had greater
body weights than control pigs on day 58. A recent study by Kim et al. (2005) also
showed that piglets fed apramycin, carbadox, and chlortetracycline had an increase in
weight gains compared to pigs fed the control diets. Pigs supplemented with SDPP in our
study had higher body weights than the control group on days 28 and 58 of trial. This
finding is related to the investigation reported by Pierce and coworkers (2005), who
indicated that feeding porcine plasma increased growth performance 7 days after
weaning. The increase in growth performance observed by feeding porcine plasma may
be associated with immunoglobulin molecules in the plasma product. In addition, the
current study could also indicate that Salmonella infection triggered by such a challenge
may not be severe enough to affect growth performance.
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In this investigation, most pigs developed evidence of infection, including watery
diarrhea and fever, 24 h following inoculation with Salmonella Typhimurium.

Cote et

al. (2004) noted that clinical signs associated with salmonellosis in pigs include
“yellowish-diarrhea, fever, prostration, and/or mortality”. We observed average higher
rectal temperatures in all treatment groups of 40.07 °C 24 h post-inoculation, which is
similar to what has been reported for pigs exhibiting signs of systemic salmonellosis
(Pfizer Animal Health, 2006). That report indicates rectal temperatures as high as 40.5
°C to 41.6 °C after 24 to 48 h incubation following infection. In the current study,
increased rectal temperatures on day 8 of trial were greater than reported by Bollen and
coworkers (2000), who indicated that normal body temperature of swine is 38-39°C.
Similarly, work by Balaji and coworkers (2000), showed that pigs (35 days old) orally
challenged with 3 × 109 CFU of Salmonella Typhimurium had an increase in rectal
temperatures by 12 h and had the highest rectal temperature at 42 h compared to control
pigs. Higher rectal temperatures of challenged pigs were maintained through 5 days after
challenge. Another study also showed that weaned pigs (24 days old) had increased
rectal temperatures to a maximum (~ 40.7 °C) 2 days after pigs orally challenged with 6 ×
109 CFU of Salmonella Typhimurium and decreased rectal temperatures (~ 40.2 °C) were
detected 3 days after Salmonella inoculation. Rectal temperatures of challenged pigs
(~39.9 °C) were not different from control pigs (~39.8 °C) 4 days after challenge (Turner
et al., 2002). Our study shows that rectal temperatures of pigs in all treatments decreased
by day 12 of trial or 5 days after challenge. However, daily rectal temperatures were not
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measured from day 8 to day 12, so variations in rectal temperatures during this period
cannot be determined.
In our study, rectal temperatures in pigs fed oxytetracycline were lower relative to
pigs fed spray dried porcine plasma and egg yolk powder containing ASEYA.

A

previous study of calves challenged with Salmonella Typhimurium, showed that
therapeutic dosages of oxytetracycline resulted in a more rapid decline of body
temperature following challenge (Remillard et al., 1981). Therefore, it is possible that
sub-therapeutic levels of antibiotics may reduce the numbers of Salmonella which infect
the host, thus limiting the rise of body temperature. In our study, significant differences
were observed but the range was only 0.5 °C which suggests biological responses were
similar 24 h after challenge.
In our study, rectal temperatures of pigs fed egg yolk powder containing ASEYA
were not different from pigs fed the control diet, apramycin and carbadox, egg yolk
powder without ASEYA and SDPP. In contrast to our results, Yokoyama and coworkers
(1998a) indicated that direct oral supplementation of isolated specific egg yolk antibodies
against outer membrane protein, lipopolysaccharide, and flagella antigens of either
Salmonella Typhimurium or Salmonella Enteritidis in solution for 3 days, 3 times per
day, can diminish and protect against the virulence of Salmonella antigens in mice.
These researchers further stated that, in animal studies, some factors including “challenge
dose”, “host susceptibility”, and “bacterial pathogenicity” may influence the
consequences of bacterial colonization even though specific antibodies have the same
degree of activity to block bacterial attachment to gut epithelium.
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In our study, only one pig from the control group in the second replicate trial died
2 weeks after inoculation. However, no other mortalities occurred in pigs fed antibiotics,
egg yolk powder containing ASEYA, egg yolk powder without ASEYA, and SDPP. In
contrast to our study, Van Dijk and coworkers (2002) reported that feeding 8% SDPP in
weaned pigs (19 days old) challenged with pathogenic E. coli was not efficient to prevent
mortality compared to weaned pigs fed control feed. However, other studies showed
similar outcomes when compared to our study.

Specific egg yolk antibody

supplementation of calves by Yokoyama and coworkers (1998b) showed that 7 days postinoculation no mortalities occurred in newborn calves orally inoculated with 1011 CFU
Salmonella Typhimurium and fed commercial milk containing specific egg yolk
antibodies against Salmonella Typhimurium at the highest concentration (1:1000).
Whereas no survival was observed in calves fed similar egg antibodies at very low
concentrations (1:<10). In the same study, researchers also found a longer onset period
of fever in calves receiving specific egg yolk antibodies at high concentrations (1:1000)
compared to calves supplemented at the lowest concentration (1:<10). Presumably, the
numbers of bacteria required to cause infection by attaching to the target enterocytes may
be lowered by specific yolk antibodies and reduce the level of infection and subsequent
change in temperature.
In comparison between our study and the investigation by Yokoyama et al.
(1998b) which observed a significant effect of Salmonella egg yolk antibodies on disease
severity in calves, other than species differences, these researchers inoculated the
infective Salmonella dose orally whereas we infected pigs orally and nasally.

The

inoculated routes may impact the consequences of egg yolk antibody used for control of
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intestinal disease since egg yolk antibody potentially active at gut level. Furthermore,
differences of digestive tract conditions between newborn calves from previous study and
weaned pigs from our study may affect control of Salmonella infection when egg yolk
antibodies were provided to animals. Findlay (1998) indicated that development of
enzymatic activities and intestinal functions rely on animal ages and feed types.
Newborn calves have incompletely developed gastrointestinal functions, particularly acid
conditions in abomasums (Moran, 2002). Therefore, providing IgY to newborn calves
may allow immunoglobulin molecules to pass through the digestive mechanisms in the
stomach and remain active at intestinal sites. However, pigs in the weaning stage have
better development of the digestive system, i.e., higher digestive enzyme secretions and
activities in the gastrointestinal tract and greater acidic conditions in the stomach because
weaned pigs start non-milk containing diets (Efird et al., 1982; Makkink et al., 1994).
Thus, feeding egg yolk antibodies to weaned pigs, IgY may be digested during the
digestive processes, resulting in IgY losing activity before immunoglobulin molecules
reach the intestine. Another possible reason for observed differences is that calves
received specific egg yolk antibodies which were directly diluted with milk, whereas
weaned pigs in our study obtained egg yolk powder containing ASEYA mixed in dry
feed. Specific yolk antibodies might be affected during feed mixing. In addition, these
researchers directly fed individual calves with milk containing specific egg yolk
antibodies, in contrast to our study where we fed pigs in a group setting. As a result, all
pigs might not have received egg yolk powder containing ASEYA equally.
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Immunological Response
Factors that may impact the host response to Salmonella infection, as indicated by
Mastroeni (2002), are “bacterial virulence”, “infectious dose” and “immunological status
of host”. These factors may be responsible for different disease severity and influence
various consequences of systemic infection by Salmonella. In this study, we challenged
weaned pigs with Salmonella concentration of 7.95×107 and 1.90×108 CFU/ml for the
first and second replicate trials, respectively, which were higher than suggested dose of
Salmonella Typhimurium (>103 CFU/ml), which causes acute infection in young pigs
(Loynachan and Harris, 2005).
In our study, weaned pigs were orally and nasally challenged with Salmonella
Typhimurium to simulate the conditions of gastrointestinal and systemic infection caused
by Salmonella. After inoculation, the body develops an immune response to Salmonella
infection (Mizuno, 2004). Our results indicate that predominant responses in pigs from
all groups following challenge were increased white blood cell counts (1-7 days postinoculation) and Salmonella antibody titers (7-21 days post-inoculation). The increase in
white blood cells was similar to that of Wick (2004), who determined the increase in
white blood cells was due to increase macrophages, neutrophils, dendritic cells, natural
killer cells, and killer T cells following Salmonella infection. However, Turner and
coworkers (2002) observed that Salmonella Typhimurium challenge did not significantly
impact total serum immunoglobulin G (IgG) in 24-days-old pigs; although an increasing
trend of IgG was observed over the course of study (0-14 days post-challenge).
Steinbach and coworkers (2003) also reported an increase in specific serum
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immunoglobulin G levels of pigs (14-70 days old) 7 days after oral Salmonella
Typhimurium infection and continued to elevate after 14 and 21 days of infection (the
end of study). Gray and coworkers (1995) also reported that pigs (10-14 days old)
challenged with Salmonella Choleraesuis had an increase in specific serum
immunoglobulin G from week 2 to week 12 after Salmonella challenge by intranasal and
gastric routes. In our study, if we analyze serum antibody a longer period in pigs infected
with Salmonella, greater increases may be observed.
In the present study, mean Salmonella antibody responses across all days were
similar among pigs for all treatment groups. Dietary treatments also did not affect white
blood cell counts among all groups of pigs. The varying numbers of white blood cells
observed through this study were in the normal range of 6.3-21.1 103/ml (Bollen et al.,
2000), but average numbers of white blood cells tended to be greater 7 days postchallenge in pigs fed non-medicated diets compared to those receiving antibiotics. These
data may indicate that antibiotic diminishes the numbers of Salmonella Typhimurium in
the intestine, possibly lowering immune induction by Salmonella pathogens as observed
in studies examining the use of olaquindox and cyadox in controlling E. coli infection
(Ding et al., 2006b).
Throughout the duration of this study, interleukin-1β (IL-1β) was detected in only
5 pigs and those levels were low with the range of 3 to 5 pg/ml. In response to bacterial
infection, interleukin-1 has been associated with fever, increasing lymphocyte responses,
and inducing acute-phase responses (Curfs et al., 1997).

Dinarello (1994) also has

reported that several systemic effects are induced by interleukin-1 as “femtomolar”. In
our study, only one of 5 pigs (control group) in which IL-1β was detected had fever
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(40.22 °C) and Salmonella shedding on day 21 of trial. Our result showed low serum IL1β after Salmonella challenge. However, the assay we used for IL-1β analysis has
sensitivity to detect ~15 pg/ml or approximately 882 pM which is higher than the
potential active range which can be “femtomolar”. Therefore, this assay is not sensitive
enough to detect very low levels of IL-1β in pigs. In our study, we analyzed IL-1β 24 h
after challenge.

In general, an increase in IL-1β has been reported 6-12 h after

lipopolysaccharide activation of endothelial cells in vitro (McGuire et al., 2005).
The relatively low level of systemic immune responses observed in our study may
be linked to local immune protection in the intestinal tract. Wijburg and coworkers
(2006) indicate that Salmonella Typhimurium bacteria were bound by non-specific
secretory immunoglobulin A stimulated by microflora in the gut mucosa of mice, thereby
minimizing the ability of invasive bacteria to invade and activate systemic responses.
Additionally,

Lorenz

and

Newberry

(2004)

reported

that

increased

specific

immunoglobulin A in gut mucosa can protect challenged Salmonella Typhimurium at
intestinal level. During penetration by Salmonella Typhimurium, local cytokines and
chemokines, such as IL-8 and CCL20, in the alimentary tract of pigs are secreted to
recruit neutrophils and dendritic cells, respectively, for control of invasive pathogens
(Skjolaas et al., 2006).
Feeding of anti-Salmonella egg yolk antibodies did not affect measured immune
responses in weaned pigs inoculated with Salmonella Typhimurium. This is possibly
explained by natural invasion of gut epithelial cells by Salmonella (Sansonetti, 2002),
thereby escaping adherence to specific yolk antibodies in the gut lumen. In addition, the
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stability of antibodies in egg yolk may be less in the pig gastrointestinal tract due to
digestive environments and mechanisms; thus, antibodies would be less able to bind
Salmonella bacteria before they invade the gut epithelium cells (Letellier et al., 1999).
In this study, we observed no correlation among Salmonella shedding, body
weight, rectal temperature, Salmonella antibody, white blood cell counts, and IL-1β.
The lack of effect of Salmonella challenge on growth performance may be because
shedding bacteria may not have infected the body or may have infected the pig less
severely. Rectal temperatures, Salmonella antibody, white blood cell counts, and IL-1β
also are independent. This is possibly explained that, after challenge, Salmonella bacteria
get into the host body through oral and nasal routes, reside in the body, and are excreted
in feces (Salmonella shedding). By the oral challenge, Salmonella bacteria pass through
the digestive tract until they reach the intestinal target and disseminate through inner
systems as indicated by Wood et al. (1989). By the intranasal inoculation, Salmonella
bacteria are able to penetrate the tonsils and lung and circulate through the lymphatic
system toward internal organs, i.e., ileum, cecum, colon, spleen, liver (Fedorka-Cray et
al., 1995). When Salmonella bacteria are in the intestinal tract, systemic circulation or
inner organs, they may not cause infection; on the other hand, pigs may only carry
Salmonella in body and then shed in feces. Ekperigin and Nagaraja (1998) indicated that
Salmonella bacteria, which do not cause infection, possibly colonize in intestinal tract,
mingle with normal flora, and excrete in feces. Pigs that obtain Salmonella may be
carriers of Salmonella after they recover from infection (Ekperigin and Nagaraja, 1998)
or most pigs just carry Salmonella with healthy appearance (Cote et al., 2004). These
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carrier pigs are sources of Salmonella contamination on farms, slaughter environments,
or pork products.
The outcomes of controlling shedding, health, infectious incidence and immune
response by providing specific chicken egg yolk antibodies against Salmonella antigens
in this study were different from previous studies (Yokoyama et al., 1998a; Yokoyama et
al., 1999b). These may vary depending on host species, animal ages, gastrointestinal
structures and functions of hosts, antibody application method, and duration of antibody
supplementation. Additionally, some reports show that specific yolk antibody dose is
important for efficient use to inhibit bacterial attachment and control animal mortality
(Jin et al., 1998; Yokoyama et al., 1998b). Uses of specific egg yolk antibodies against
Salmonella antigens in protection of Salmonella infectious disease and prevention
bacterial shedding are limited in weaned pigs experimentally inoculated with Salmonella
by intranasal and oral routes, whereas antibiotics are effective to control Salmonella
shedding and incidence of Salmonella infection. However, use of in-feed antibiotics
promotes the ability of non-pathogenic E. coli in the intestine to resistant antibiotics,
resulting in large public health concerns.
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Feeding egg yolk powder containing anti-Salmonella egg yolk antibody to
weaned pigs orally and nasally challenged with Salmonella Typhimurium was not
effective in controlling Salmonella shedding, did not affect growth performance, and did
not provide obvious health benefits. Our current work indicates little benefit of antiSalmonella egg yolk antibody in reducing risks of Salmonella in pigs which result in
contamination of pork products via shedding in market animals. In contrast, antibiotic
regimens appear to offer some benefits in reducing shedding and controlling infection in
young pigs. However, in-feed inclusion of anti-Salmonella egg yolk antibody did not
appear to add additional risks associated with antibiotic resistant bacteria. Further studies
that include confirmation of anti-Salmonella egg yolk antibody stability in
gastrointestinal tract, possible uses in mature animals, antibody stability or loss during
feed mill processing and storage, and applications for large quantity use in commercial
animal production will be necessary.
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Table 1. Treatments applied to pig groups (n=22 pigs/treatment in 2 replicate trials)
Treatment

Description

Control (C)

Control diet formulated at or above 1998 NRC
recommendations.

Apramycin1 and
Carbadox2
(APR+CB)

Control treatment plus apramycin at 150 g/ton for 14 days,
followed by carbadox at 25 g/ton until pigs reached 35 kg.

Oxytetracycline3
(OXY)

Control treatment plus oxytetracycline at 100 g/ton of feed
until pigs reached 35 kg.

Anti-Salmonella egg
yolk antibodies4
(ASEYA)

Control treatment plus egg yolk powder with antibodies
specific to Salmonella Typhimurium at a level of 6 kg/ton of
feed for 14 days

Egg yolk antibodies
without ASEYA5
(EY)

Control treatment plus egg yolk powder without antibodies
specific to Salmonella Typhimurium at a level of 6 kg/ton of
feed for 14 days

Spray dried porcine6
plasma (SDPP)

Control treatment plus spray dried porcine plasma at a level
of 3 % of feed for 14 days

1

Apramycin (Apralan G 20; Elanco Animal Health, Greenfield, IN)
Carbadox (Madcadox 10; Phibro Animal Health, Ridgefield Park, NJ)
3
Oxytetracycline (Phoenix Scientific, Inc., St. Joseph, MO)
4
Dried egg yolk powder (University of Manitoba, Winnipeg, Canada)
5
Spray dried pasteurized egg yolk powder (Primera Foods, Cameron, WI)
6
Spray dried porcine plasma (AP920; American Protein Corp, Ankeny, IA)
2
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Table 2. Composition of treatment diets (Phase I1: for 14 days)
Diet2
Item

C

APR+CB

OXY

ASEYA

EY

SDPP

Corn

55.70

55.68

55.70

55.70

55.70

58.20

Soy Bean Meal, 48%

33.65

33.65

33.70

33.05

33.05

28.30

Fish meal

5.00

5.00

5.00

5.00

5.00

5.00

Salt (NaCl)

0.15

0.15

0.15

0.15

0.15

0.15

Vitamin/Mineral
Premix3

2.50

2.50

2.50

2.50

2.50

2.50

Animal Fat4

3.00

3.00

3.00

3.00

3.00

3.00

APR

-

0.015

-

-

-

-

OXY

-

-

0.01

-

-

-

ASEYA

-

-

-

0.60

-

-

EY

-

-

-

-

0.60

-

SDPP

-

-

-

-

-

3.00

23.50

23.50

23.50

23.40

23.40

23.40

ME, Kcal/kg

3,428.3

3,427.6

3,427.8

3,407.8

3,407.8

3,442.3

Calcium, %

1.01

1.01

1.01

1.01

1.01

1.0

Total phosphorus, %

0.73

0.73

0.73

0.73

0.73

0.75

Available P5, %

0.43

0.43

0.43

0.43

0.43

0.48

Ingredients, %

Calculated nutrient composition
Crude protein, %

1.45
1.40
1.40
1.40
1.40
1.40
Lysine, %
Based on 23.7% crude protein, 1.35% lysine (total basis) (NRC, 1998)
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Co-op Swine Base Mix “50” (Tennessee Farmers Cooperative, LaVergne, TN)
4
Co-op FAT MIX “30” (Tennessee Cooperative, LaVergne, TN)
5
Available phosphorus
1
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Table 3. Composition of treatment diets (Phase II1: after 14 days until 20 kg)
Diet2
Item

C

APR+CB

OXY

ASEYA

EY

SDPP

Corn

60.85

60.85

60.84

60.85

60.85

58.20

Soy Bean Meal, 48%

28.50

28.50

28.50

28.50

28.50

28.30

Fish meal

5.00

5.00

5.00

5.00

5.00

5.00

Salt (NaCl)

0.15

0.15

0.15

0.15

0.15

0.15

Vitamin/Mineral Premix3

2.50

2.50

2.50

2.50

2.50

2.50

Animal Fat4

3.00

3.00

3.00

3.00

3.00

3.00

CB

-

0.003

-

-

-

-

OXY

-

-

0.01

-

-

-

21.50

21.50

21.50

21.40

21.40

21.40

ME, Kcal/kg

3,427.6

3,427.6

3,427.6

3,427.6

3,427.6

3,427.6

Calcium, %

1.00

1.00

1.00

1.00

1.00

1.00

Total phosphorus, %

0.71

0.71

0.71

0.71

0.71

0.71

Available P5, %

0.43

0.43

0.43

0.43

0.43

0.43

Ingredient, %

Calculated nutrient composition
Crude protein, %

1.26
1.26
1.26
1.26
1.26
1.26
Lysine, %
Based on 20.9% crude protein, 1.15% lysine (total basis) (NRC, 1998)
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Co-op Swine Base Mix “50” (Tennessee Farmers Cooperative, LaVergne,TN)
4
Co-op FAT MIX “30” (Tennessee Cooperative, LaVergne, TN)
5
Available phosphorus
1
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Table 4. Composition of treatment diets (Phase III1: from 20 kg until 35 kg)
Diet2
Item

C

APR+CB

OXY

ASEYA

EY

SDPP

Corn

66.35

66.34

66.34

66.35

66.35

66.35

Soy Bean Meal, 48%

24.00

24.00

24.00

24.00

24.00

24.00

Fish meal

4.00

4.00

4.00

4.00

4.00

4.00

Salt (NaCl)

0.15

0.15

0.15

0.15

0.15

0.15

Vitamin/Mineral
Premix3

2.50

2.50

2.50

2.50

2.50

2.50

Animal Fat4

3.00

3.00

3.00

3.00

3.00

3.00

CB

-

0.003

-

-

-

-

OXY

-

-

0.01

-

-

-

19.20

19.20

19.20

19.20

19.20

19.20

ME, Kcal/kg

3,426.7

3,426.7

3,426.7

3,426.7

3,426.7

3,426.7

Calcium, %

0.94

0.94

0.94

0.94

0.94

0.94

Total phosphorus, %

0.67

0.67

0.67

0.67

0.67

0.67

Available P5, %

0.39

0.39

0.39

0.39

0.39

0.39

Ingredient, %

Calculated nutrient composition
Crude protein, %

1.09
1.09
1.09
1.09
1.09
1.09
Lysine, %
Based on 18.0% crude protein, 0.95% lysine (NRC, 1998)
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Co-op Swine Base Mix “50” (Tennessee Farmers Cooperative, LaVergne, TN)
4
Co-op FAT MIX “30” (Tennessee Cooperative, LaVergne, TN)
5
Available phosphorus
1
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Table 5. MIC Breakpoints for antibiotics and antibiotic dilution ranges for Salmonella
enterica Typhimurium and E. coli
Bacterial types
Salmonella Typhimurium

E. coli
Breakpoint,

Dilution range,

Breakpoint,

Dilution range,

Antibiotic types

µg/ml

µg/ml

µg/ml

µg/ml

Tetracycline

≥161,2

0-128

≥161,2

0-128

Apramycin

≥322

0-128

≥322

0-128

Carbadox

≥643

0-128

≥643

0-128

1

National Committee for Clinical Laboratory Standards, 2002
National Antimicrobial Resistance Monitoring System—Enteric Bacteria, 2001
3
Danish Integrated Antimicrobial Resistance Monitoring and Research Program, 1999
2
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Table 6. Effect of dietary treatments on various days on percentage of pigs shedding
Salmonella Typhimurium1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

0

0

0

0

0

0

0g

74

0

0

0

0

0

0

0g

8

100

77.27

86.36

100

100

100

93.94a

12

95.45

27.27

63.64

86.36

95.45

100

78.03b

14

86.36

22.73

36.36

86.36

100

100

71.97b

21

77.27

40.91

54.55

59.09

63.64

59.09

59.09c

28

59.09

40.91

22.73

59.09

50.00

54.55

47.73d

58

13.64

27.27

13.64

31.82

4.54

0

15.15f

88

31.82

45.45

27.27

36.36

40.91

22.73

34.09e
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27.27

27.27

0

0

9.09

4.54

11.36f

Treatment
Mean

61.36x

38.64y

38.07y

57.39x

57.95x

55.11x

a-g

Means within a column without a common superscript letter differ (P<0.05).
Means within a row without a common superscript letter differ (P<0.05).
1
Data are least squares means from two replicate trials (n = 22 pigs/treatment).
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Treatment effects (P<0.0001).
Day effects (P<0.0001).
Treatment × Day effects (P<0.0001).
SEM = 4.65, 4.78 and 8.90 for treatment, day, and interaction means, respectively.
x-y
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Table 7. Effect of dietary treatments on various days on percentage of pigs shedding E.
coli1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

100

100

100

100

100

100

100a

74

100

81.82

100

100

95.45

100

96.21ab

8

95.45

90.91

100

100

95.45

95.45

96.21ab

12

100

95.45

95.45

95.45

100

100

97.73ab

14

90.91

100

95.45

81.82

100

100

94.70abc

21

95.45

100

77.27

77.27

86.36

95.45

88.64d

28

95.45

90.91

86.36

100

90.91

100

93.94bc

58

95.45

77.27

90.91

68.18

100

90.91

87.12d

88

95.45

90.91

100

100

100

95.45

96.97ab

118

90.91

90.91

100

95.45

81.82

81.82

90.15cd

Treatment
Mean

95.91

91.82

94.55

91.82

95.00

95.91

a-d

Means within a column without a common superscript letter differ (P<0.05).
Data are least squares means from two replicate trials (n = 22 pigs/treatment).
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Day effects (P<0.0001)
Treatment × Day effects (P<0.0001)
SEM = 2.53, 2.63 and 5.14 for treatment, day, and interaction means, respectively.
1
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Table 8. Effect of dietary treatments on various days on tetracycline resistance of E. coli
(%) isolated from pigs1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

97.73

87.50

97.73

76.14

85.23

82.95

87.88a

74

76.14

71.59

93.18

79.55

82.95

71.59

79.17b

8

65.91

82.95

97.73

79.55

84.09

75.00

80.87ab

12

65.91

75.00

94.32

43.18

87.50

59.09

70.83c

14

57.95

72.73

93.18

34.09

80.63

71.59

68.37cd

21

70.45

78.41

77.27

39.77

72.73

65.91

67.42cd

28

68.18

53.41

80.68

65.91

52.27

57.95

63.07cd

58

71.59

37.50

78.41

23.86

86.36

63.64

60.23d

88

68.18

65.91

89.77

61.36

45.45

48.86

63.26cd

118

59.09

53.41

85.23

65.91

75.00

48.86

64.58cd

Treatment
Mean

70.11xy

67.84xy

88.75w

56.93z

75.23x

64.55y

a-d

Means within a column without a common superscript letter differ (P<0.05).
Means within a row without a common superscript letter differ (P<0.05).
1
Data are least squares means from two replicate trials with a total of 4,763 isolates.
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Treatment effects (P<0.0001).
Day effects (P<0.0001).
Treatment × Day effects (P<0.0001).
SEM = 6.98, 7.11 and 9.75 for treatment, day, and interaction means, respectively.
w-z
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Table 9. Effect of dietary treatments on various days on apramycin resistance of E. coli
(%) isolated from pigs1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

6.82

0

5.68

0

1.14

0

2.27d

74

1.14

55.68

3.41

6.82

11.36

3.41

13.64a

8

0

84.09

2.27

2.27

0

1.14

14.96a

12

1.14

85.23

0

0

0

0

14.39a

14

0

86.36

4.54

2.27

0

0

15.53a

21

2.27

84.09

1.14

2.27

3.41

5.68

16.48a

28

0

40.91

3.41

0

0

1.14

7.58bc

58

3.41

12.50

12.50

9.10

14.77

3.41

9.28b

88

5.68

7.96

3.41

7.96

1.14

5.68

5.30cd

118

2.27

5.68

4.54

4.54

10.23

9.10

6.06bc

Treatment
Mean

2.27y

46.25x

4.09y

3.52y

4.20y

2.95y

a-d

Means within a column without a common superscript letter differ (P<0.05).
Means within a row without a common superscript letter differ (P<0.05).
1
Data are least squares means from two replicate trials with a total of 4,763 isolates.
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Treatment effects (P<0.0001).
Day effects (P<0.0001).
Treatment × Day effects (P<0.0001).
SEM = 2.97, 3.01 and 4.24 for treatment, day, and interaction means, respectively.
x-y
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Table 10. Effect of dietary treatments on various days on carbadox resistance of E. coli
(%) isolated from pigs1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

0

0

6.82

0

2.27

0

1.52bc

74

0

0

2.27

1.14

2.27

4.54

1.71bc

8

0

0

0

0

0

2.27

0.38c

12

0

0

0

0

0

0

0c

14

0

0

0

1.14

1.14

1.14

0.57bc

21

0

0

2.27

0

0

7.96

1.71bc

28

0

10.23

3.41

1.14

0

0

2.46b

58

0

20.45

5.68

1.14

0

1.14

4.73a

88

0

2.27

0

0

1.14

0

0.57bc

118

0

0

0

0

1.14

2.27

0.57bc

Treatment
Mean

0z

3.29w

2.04wx

0.45yz

0.79xyz

1.93wxy

a-c

Means within a column without a common superscript letter differ (P<0.05).
Means within a row without a common superscript letter differ (P<0.05).
1
Data are least squares means from two replicate trials with a total of 4,763 isolates.
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Treatment effects (P<0.001).
Day effects (P<0.0001).
Treatment × Day effects (P<0.0001).
SEM = 1.05, 1.13 and 1.91 for treatment, day, and interaction means, respectively.
w-z
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Table 11. Effect of dietary treatments on various days on body weights (kg) in pigs
challenged with Salmonella Typhimurium1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

7.88

8.83

8.26

8.91

9.14

9.30

8.72h

74

12.26

13.65

12.68

13.27

13.43

13.83

13.19g

8

12.50

14.04

13.15

13.45

13.65

13.88

13.45g

12

13.51

16.51

14.59

13.33

14.81

15.02

14.63f

14

14.73

18.10

17.13

16.24

16.65

17.05

16.65e

21

19.56

23.60

22.09

20.83

21.43

21.82

21.55d

28

24.38

29.50

27.58

26.94

27.27

27.96

27.27c

58

48.98

53.74

52.37

51.11

51.67

52.98

51.81b

88

80.13

82.52

78.06

81.38

82.50

79.93

80.75a

Treatment
Mean

25.99

28.94

27.32

27.27

27.84

27.97

a-h

Means within a column without a common superscript letter differ (P<0.05).
Data are least squares means from two replicate trials (n = 22 pigs/treatment).
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Day effects (P<0.0001).
Treatment × Day effects (P<0.01)
SEM = 0.93, 0.49 and 1.16 for treatment, day, and interaction means, respectively.
1
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Table 12. Effect of dietary treatments on various days on rectal temperature (°C) in pigs
challenged with Salmonella Typhimurium1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

39.56

39.25

39.50

39.73

39.83

39.69

39.60bc

74

39.77

39.71

39.43

39.74

39.56

39.79

39.67b

8

40.10

39.85

39.99

40.08

40.10

40.30

40.07a

12

39.45

39.52

39.32

39.46

39.59

39.73

39.51c

14

39.33

39.75

39.57

39.66

39.49

39.63

39.57bc

21

39.76

39.71

39.48

39.56

39.42

39.63

39.59bc

28

39.50

39.50

39.47

39.72

39.64

39.63

39.58bc

Treatment
Mean

39.64yz

39.61yz

39.54z

39.71xy

39.66xyz

39.77x

a-c

Means within a column without a common superscript letter differ (P<0.05).
Means within a row without a common superscript letter differ (P<0.05).
1
Data are least squares means from two replicate trials (n = 12 pigs/treatment).
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Treatment effects (P<0.05).
Day effects (P<0.0001).
Treatment × Day effects (P<0.0001).
SEM = 0.069, 0.065 and 0.104 for treatment, day, and interaction means, respectively.
x-z
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Table 13. Effect of dietary treatments on various days on white blood cell counts
(×103/ml) in pigs challenged with Salmonella Typhimurium1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

13.04

11.17

12.63

12.20

12.95

11.94

12.32e

74

16.73

15.54

16.79

15.82

15.79

14.26

15.82cd

8

16.74

19.39

19.63

19.68

16.91

16.53

18.14ab

12

21.12

15.31

16.77

17.98

20.21

19.31

18.45a

14

21.03

16.96

14.74

20.83

20.10

21.11

19.13a

21

19.06

13.20

15.77

18.32

17.36

17.39

16.85bc

28

19.74

10.76

12.74

15.11

15.08

17.78

15.20d

Treatment
Mean

18.21

14.61

15.58

17.13

16.91

16.90

a-e

Means within a column without a common superscript letter differ (P<0.05).
Data are least squares means from two replicate trials (n = 12 pigs/treatment).
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Day effects (P<0.0001).
Treatment × Day effects (P<0.01).
SEM = 2.06, 1.98 and 2.35 for treatment, day, and interaction means, respectively.
1

122

Table 14. Effect of dietary treatments on various days on serum Salmonella antibody in
pigs challenged with Salmonella Typhimurium1
Treatment2
Day3

C

APR+CB

OXY

ASEYA

EY

SDPP

Day
Mean

0

0.022

0.053

0.029

0.034

0.063

0.060

0.043d

74

0.008

0.026

0.008

0.009

0.018

0.019

0.015d

8

0.009

0.021

0.005

0.013

0.013

0.022

0.014d

12

0.034

0.017

0.016

0.063

0.018

0.027

0.029d

14

0.158

0.068

0.165

0.226

0.067

0.092

0.129c

21

0.255

0.183

0.274

0.429

0.184

0.177

0.250b

28

0.824

0.370

0.530

0.636

0.485

0.493

0.556a

Treatment
Mean

0.187

0.105

0.147

0.202

0.121

0.127

a-d

Means within a column without a common superscript letter differ (P<0.05).
Data are least squares means of S/P ratio from two replicate trials
(n = 12 pigs/treatment)
2
C
= Control diet without antibiotics or egg yolk products
APR+CB
= Control diet + apramycin followed by carbadox
OXY
= Control diet + oxytetracycline
ASEYA
= Control diet + egg yolk powder containing anti-Salmonella antibody
EY
= Control diet + egg yolk powder without anti-Salmonella antibody
SDPP
= Control diet + spray dried porcine plasma
3
Days of experiment.
4
All pigs were challenged with Salmonella Typhimurium on day 7.
Day effects (P<0.0001).
SEM = 0.064, 0.041 and 0.086 for treatment, day, and interaction means, respectively.
1
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